Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   psoriasis
  

Disease ID 64
Disease psoriasis
Definition
A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
Synonym
psoriases
psoriasi
psoriasis (disorder)
psoriasis [disease/finding]
psoriasis nos
psoriasis nos (disorder)
psoriasis unspecified
psoriasis unspecified (disorder)
psoriasis, nos
DOID
UMLS
C0033860
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:216)
C0003864  |  arthritis  |  76
C0003872  |  psoriatic arthritis  |  45
C0948265  |  metabolic syndrome  |  31
C0028754  |  obesity  |  29
C0003864  |  inflammatory arthritis  |  28
C0011570  |  depression  |  23
C0042373  |  vascular disease  |  21
C0007222  |  cardiovascular disease  |  19
C0011847  |  diabetes  |  18
C0041296  |  tuberculosis  |  16
C0020538  |  hypertension  |  14
C0019158  |  hepatitis  |  11
C0022408  |  arthropathy  |  10
C0019196  |  hepatitis c  |  10
C0004153  |  atherosclerosis  |  9
C0021831  |  bowel disease  |  9
C0021390  |  inflammatory bowel disease  |  8
C0027051  |  myocardial infarction  |  7
C0027051  |  myocardial infarct  |  7
C0030805  |  pemphigoid  |  7
C0021053  |  immune disease  |  6
C0003467  |  anxiety  |  6
C0042373  |  vascular diseases  |  6
C0011603  |  dermatitis  |  6
C0007222  |  cardiovascular diseases  |  6
C0002170  |  alopecia  |  5
C0011615  |  atopic dermatitis  |  5
C0010068  |  coronary artery disease  |  5
C0038013  |  ankylosing spondylitis  |  5
C0030805  |  bullous pemphigoid  |  5
C0026769  |  multiple sclerosis  |  5
C0007137  |  squamous cell carcinoma  |  5
C0040261  |  onychomycosis  |  5
C0030807  |  pemphigus  |  4
C0010346  |  crohn's disease  |  4
C0037274  |  skin disease  |  4
C0011849  |  diabetes mellitus  |  4
C0038012  |  spondylitis  |  4
C0042769  |  virus infection  |  4
C0031099  |  periodontitis  |  4
C0033953  |  sexual dysfunction  |  4
C0003873  |  rheumatoid arthritis  |  4
C0007222  |  cardiovascular disorders  |  3
C0018799  |  heart disease  |  3
C0020456  |  hyperglycemia  |  3
C0035078  |  renal failure  |  3
C0042373  |  vascular disorders  |  3
C0030809  |  pemphigus vulgaris  |  3
C0028754  |  adiposity  |  3
C0013595  |  eczema  |  3
C0037274  |  skin diseases  |  3
C0162836  |  hidradenitis suppurativa  |  3
C0085160  |  hidradenitis  |  3
C0042373  |  vascular disorder  |  3
C0024299  |  lymphoma  |  3
C0019360  |  herpes zoster  |  2
C0019360  |  zoster  |  2
C0023418  |  leukaemia  |  2
C0024141  |  systemic lupus erythematosus  |  2
C0019196  |  hepatitis c infection  |  2
C0878544  |  cardiomyopathy  |  2
C0019163  |  hepatitis b  |  2
C0035435  |  rheumatic diseases  |  2
C0022408  |  joint disease  |  2
C0011860  |  type 2 diabetes  |  2
C0042870  |  vitamin d deficiency  |  2
C0409974  |  lupus erythematosus  |  2
C0042164  |  uveitis  |  2
C0023895  |  liver disease  |  2
C0042870  |  vitamin d defic  |  2
C0870082  |  hyperkeratosis  |  2
C0242490  |  enthesopathy  |  2
C0027051  |  myocardial infarction (mi)  |  2
C0020443  |  hypercholesterolemia  |  2
C0003872  |  psoriatic arthropathy  |  2
C0022408  |  articular disease  |  2
C0011616  |  contact dermatitis  |  2
C0042900  |  vitiligo  |  2
C0035435  |  rheumatic disease  |  2
C0039103  |  synovitis  |  2
C1261473  |  sarcoma  |  2
C0004096  |  asthma  |  2
C0022658  |  renal disease  |  2
C0042384  |  vasculitis  |  1
C0011860  |  type 2 diabetes mellitus  |  1
C0039494  |  temporomandibular disorders  |  1
C0003469  |  anxiety disorders  |  1
C0554114  |  epstein-barr virus hepatitis  |  1
C0553662  |  juvenile idiopathic arthritis  |  1
C0024143  |  lupus nephritis  |  1
C0037274  |  dermatosis  |  1
C0019655  |  histoplasmosis  |  1
C0007193  |  dilated cardiomyopathy  |  1
C0031090  |  periodontal disease  |  1
C0155626  |  acute myocardial infarction  |  1
C0085435  |  reactive arthritis  |  1
C0039128  |  syphilis  |  1
C0018099  |  gout  |  1
C0242647  |  mucosa-associated lymphoid tissue lymphoma  |  1
C0006840  |  candidosis  |  1
C0035854  |  rosacea  |  1
C0020538  |  high blood pressure  |  1
C0042721  |  viral hepatitis  |  1
C0026848  |  muscular diseases  |  1
C0037317  |  sleep disturbance  |  1
C0006663  |  calcinosis  |  1
C1704437  |  respiratory distress syndrome  |  1
C0149521  |  chronic pancreatitis  |  1
C0023343  |  leprosy  |  1
C0022661  |  chronic kidney disease  |  1
C0442874  |  neuropathy  |  1
C0022658  |  kidney disease  |  1
C0278883  |  metastatic melanoma  |  1
C0017661  |  iga nephropathy  |  1
C0022398  |  hyper ige syndrome  |  1
C0042170  |  harada disease  |  1
C0013238  |  dry eye syndrome  |  1
C0003469  |  anxiety disorder  |  1
C0028242  |  nocardiosis  |  1
C0025202  |  melanoma  |  1
C0022658  |  renal diseases  |  1
C0037274  |  skin conditions  |  1
C0039614  |  tetanus  |  1
C0553723  |  cutaneous squamous cell carcinoma  |  1
C0598608  |  hyperhomocysteinaemia  |  1
C0007570  |  celiac disease  |  1
C0042170  |  vogt-koyanagi-harada syndrome  |  1
C0024623  |  gastric cancer  |  1
C0155773  |  portal vein thrombosis  |  1
C0242350  |  erectile dysfunction  |  1
C0032453  |  relapsing polychondritis  |  1
C0035222  |  acute respiratory distress syndrome  |  1
C2607914  |  allergic rhinitis  |  1
C0032285  |  pneumonitis  |  1
C0040425  |  tonsillitis  |  1
C0949690  |  spondyloarthritis  |  1
C0030186  |  extramammary paget disease  |  1
C0751967  |  relapsing-remitting multiple sclerosis  |  1
C1314968  |  impetigo herpetiformis  |  1
C0242379  |  lung cancer  |  1
C0042170  |  vogt-koyanagi-harada disease  |  1
C0242647  |  mucosa-associated lymphoid tissue  |  1
C0403416  |  crescentic glomerulonephritis  |  1
C0019202  |  wilson's disease  |  1
C0042109  |  urticaria  |  1
C0024115  |  lung disease  |  1
C0001973  |  alcoholism  |  1
C0729771  |  throat infection  |  1
C0002726  |  amyloidosis  |  1
C1527407  |  eosinophilic pneumonia  |  1
C0079293  |  epidermolysis bullosa acquisita  |  1
C0027030  |  myiasis  |  1
C0028768  |  obsessive-compulsive disorder  |  1
C0027868  |  neuromuscular diseases  |  1
C0021053  |  immune disorders  |  1
C0001339  |  acute pancreatitis  |  1
C0006849  |  oral candidosis  |  1
C0030354  |  papilloma  |  1
C0031350  |  pharyngitis  |  1
C0020443  |  hypercholesterolaemia  |  1
C0041327  |  pulmonary tuberculosis  |  1
C0032285  |  pneumonia  |  1
C0030305  |  pancreatitis  |  1
C0151332  |  active tuberculosis  |  1
C0029401  |  paget disease  |  1
C0008311  |  cholangitis  |  1
C0036689  |  streptococcal pharyngitis  |  1
C0006840  |  candidiasis  |  1
C0021390  |  inflammatory bowel diseases  |  1
C0041408  |  turner syndrome  |  1
C0949691  |  spondyloarthropathy  |  1
C0021400  |  influenza  |  1
C0037274  |  skin disorders  |  1
C0263859  |  sapho syndrome  |  1
C0024236  |  lymphedema  |  1
C0041696  |  major depression  |  1
C0007115  |  thyroid ca  |  1
C0024115  |  pulmonary disease  |  1
C0026470  |  monoclonal gammopathy of undetermined significance  |  1
C0020498  |  diffuse idiopathic skeletal hyperostosis  |  1
C0026764  |  myeloma  |  1
C0022661  |  end-stage renal disease  |  1
C0041408  |  turner's syndrome  |  1
C0162820  |  allergic contact dermatitis  |  1
C0036202  |  sarcoidosis  |  1
C0026764  |  multiple myeloma  |  1
C0027962  |  melanocytic naevi  |  1
C0836924  |  thrombocytosis  |  1
C0039494  |  temporomandibular disorder  |  1
C0010068  |  coronary heart disease  |  1
C0040034  |  thrombocytopenia  |  1
C0023470  |  myelogenous leukaemia  |  1
C0020542  |  pulmonary hypertension  |  1
C0037274  |  skin disorder  |  1
C0036220  |  kaposi's sarcoma  |  1
C0017677  |  erythema migrans  |  1
C0029456  |  osteoporosis  |  1
C0029442  |  osteomalacia  |  1
C0007134  |  renal carcinoma  |  1
C0032461  |  polycythemia  |  1
C0314719  |  dry eye  |  1
C0027868  |  neuromuscular disease  |  1
C0026896  |  myasthenia gravis  |  1
C0031069  |  familial mediterranean fever  |  1
C0023473  |  chronic myelogenous leukaemia  |  1
C0040053  |  thrombosis  |  1
C0549473  |  thyroid carcinoma  |  1
C0270922  |  demyelinating neuropathy  |  1
C0042721  |  virus hepatitis  |  1
C0238463  |  papillary thyroid carcinoma  |  1
C1318533  |  secondary polycythemia  |  1
C0017658  |  glomerulonephritis  |  1
C0021053  |  immune disorder  |  1
C0014527  |  epidermolysis bullosa  |  1
C0021099  |  impetigo  |  1
C0027822  |  neurodermatitis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:78)
TNF  |  7124  |  CTD_human
IL6  |  3569  |  CTD_human
SOD2  |  6648  |  CTD_human
CP  |  1356  |  CTD_human
TP53  |  7157  |  CTD_human
STAT3  |  6774  |  CTD_human
HCAR2  |  338442  |  CTD_human
IL13  |  3596  |  CTD_human;GWASCAT
APOE  |  348  |  CTD_human
CRP  |  1401  |  CTD_human
REV3L  |  5980  |  GWASCAT
PCNA  |  5111  |  CTD_human
TNFAIP3  |  7128  |  CTD_human;GWASCAT
RUNX3  |  864  |  CTD_human
IL1B  |  3553  |  CTD_human
NOS2  |  4843  |  CTD_human;GWASCAT
CSF2  |  1437  |  CTD_human
SOCS1  |  8651  |  GWASCAT
KIAA0391  |  9692  |  GWASCAT
CAST  |  831  |  GWASCAT
VEGFA  |  7422  |  CTD_human
TNIP1  |  10318  |  CTD_human;GWASCAT
IL12B  |  3593  |  CTD_human;GWASCAT
HLA-C  |  3107  |  CTD_human
TYK2  |  7297  |  CTD_human;GWASCAT
PSORS10  |  503613  |  CTD_human
CAT  |  847  |  CTD_human
CSMD1  |  64478  |  CTD_human
IL23R  |  149233  |  CTD_human;GWASCAT
SPATA2  |  9825  |  GWASCAT
PPARG  |  5468  |  CTD_human
IFIH1  |  64135  |  CTD_human
ELMO1  |  9844  |  GWASCAT
ERAP1  |  51752  |  CTD_human;GWASCAT
FUT2  |  2524  |  GWASCAT
TAGAP  |  117289  |  CTD_human
TRAF3IP2-AS1  |  643749  |  GWASCAT
TGFA  |  7039  |  CTD_human
KCNH7  |  90134  |  GWASCAT
GJB2  |  2706  |  CTD_human
IL4  |  3565  |  CTD_human
CARD14  |  79092  |  CTD_human
FBXL19  |  54620  |  CTD_human;GWASCAT
VNN2  |  8875  |  CTD_human
S100A7  |  6278  |  CTD_human
SERPINB8  |  5271  |  CTD_human
REL  |  5966  |  CTD_human
REN  |  5972  |  CTD_human
MKI67  |  4288  |  CTD_human
HCP5  |  10866  |  GWASCAT
NFKBIA  |  4792  |  CTD_human
ZMIZ1  |  57178  |  GWASCAT
VNN1  |  8876  |  CTD_human
IL23A  |  51561  |  CTD_human
LCE3B  |  353143  |  CTD_human
LCE3C  |  353144  |  CTD_human
LCE3D  |  84648  |  CTD_human
QTRT1  |  81890  |  GWASCAT
PTTG1  |  9232  |  CTD_human
CYP2S1  |  29785  |  CTD_human
VNN3  |  55350  |  CTD_human
TRAF3IP2  |  10758  |  CTD_human;GWASCAT
DDX58  |  23586  |  CTD_human;GWASCAT
LINC01185  |  400957  |  GWASCAT
IFNLR1  |  163702  |  CTD_human
PSORS3  |  7889  |  CTD_human
PSORS7  |  65245  |  CTD_human
PSORS5  |  63870  |  CTD_human
PSORS4  |  10547  |  CTD_human
PSORS9  |  359825  |  CTD_human
PSORS8  |  140454  |  CTD_human
ZNF816  |  125893  |  CTD_human
RNF114  |  55905  |  CTD_human
EXOC2  |  55770  |  GWASCAT
PSORS6  |  63869  |  CTD_human
CARM1  |  10498  |  CTD_human
STAT2  |  6773  |  GWASCAT
ZC3H12C  |  85463  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:175)
4363  |  ABCC1  |  infer
9429  |  ABCG2  |  infer
1636  |  ACE  |  infer
80332  |  ADAM33  |  infer
177  |  AGER  |  infer
10554  |  AGPAT1  |  infer
348  |  APOE  |  infer
56244  |  BTNL2  |  infer
339263  |  C17orf51  |  infer
717  |  C2  |  infer
831  |  CAST  |  infer
54535  |  CCHCR1  |  infer
6347  |  CCL2  |  infer
10666  |  CD226  |  infer
54901  |  CDKAL1  |  infer
1041  |  CDSN  |  infer
57511  |  COG6  |  infer
64478  |  CSMD1  |  infer
1475  |  CSTA  |  infer
1493  |  CTLA4  |  infer
6376  |  CX3CL1  |  infer
1524  |  CX3CR1  |  infer
1543  |  CYP1A1  |  infer
780  |  DDR1  |  infer
1672  |  DEFB1  |  infer
135656  |  DPCR1  |  infer
1906  |  EDN1  |  infer
51752  |  ERAP1  |  infer
54620  |  FBXL19  |  infer
2312  |  FLG  |  infer
2706  |  GJB2  |  infer
63940  |  GPSM3  |  infer
2944  |  GSTM1  |  infer
2952  |  GSTT1  |  infer
285834  |  HCG22  |  infer
253018  |  HCG27  |  infer
10866  |  HCP5  |  infer
3105  |  HLA-A  |  infer
3106  |  HLA-B  |  infer
3107  |  HLA-C  |  infer
3108  |  HLA-DMA  |  infer
3109  |  HLA-DMB  |  infer
3112  |  HLA-DOB  |  infer
3117  |  HLA-DQA1  |  infer
3119  |  HLA-DQB1  |  infer
3123  |  HLA-DRB1  |  infer
3126  |  HLA-DRB4  |  infer
3132  |  HLA-DRB9  |  infer
3133  |  HLA-E  |  infer
3135  |  HLA-G  |  infer
267015  |  HLA-S  |  infer
3356  |  HTR2A  |  infer
8870  |  IER3  |  infer
64135  |  IFIH1  |  infer
3458  |  IFNG  |  infer
3586  |  IL10  |  infer
3592  |  IL12A  |  infer
3593  |  IL12B  |  infer
3594  |  IL12RB1  |  infer
3595  |  IL12RB2  |  infer
3596  |  IL13  |  infer
3600  |  IL15  |  infer
3557  |  IL1RN  |  infer
3558  |  IL2  |  infer
53832  |  IL20RA  |  infer
53833  |  IL20RB  |  infer
50616  |  IL22  |  infer
51561  |  IL23A  |  infer
149233  |  IL23R  |  infer
3565  |  IL4  |  infer
3566  |  IL4R  |  infer
3569  |  IL6  |  infer
3660  |  IRF2  |  infer
3663  |  IRF5  |  infer
90134  |  KCNH7  |  infer
9692  |  KIAA0391  |  infer
3802  |  KIR2DL1  |  infer
3803  |  KIR2DL2  |  infer
3804  |  KIR2DL3  |  infer
3805  |  KIR2DL4  |  infer
57292  |  KIR2DL5A  |  infer
554300  |  KIR2DP1  |  infer
3806  |  KIR2DS1  |  infer
100132285  |  KIR2DS2  |  infer
3808  |  KIR2DS3  |  infer
3809  |  KIR2DS4  |  infer
3810  |  KIR2DS5  |  infer
3811  |  KIR3DL1  |  infer
3812  |  KIR3DL2  |  infer
115653  |  KIR3DL3  |  infer
3813  |  KIR3DS1  |  infer
353142  |  LCE3A  |  infer
353143  |  LCE3B  |  infer
353144  |  LCE3C  |  infer
84648  |  LCE3D  |  infer
353145  |  LCE3E  |  infer
3952  |  LEP  |  infer
11026  |  LILRA3  |  infer
7940  |  LST1  |  infer
4049  |  LTA  |  infer
401250  |  MCCD1  |  infer
4258  |  MGST2  |  infer
100507436  |  MICA  |  infer
4277  |  MICB  |  infer
100129192  |  MICC  |  infer
4282  |  MIF  |  infer
4313  |  MMP2  |  infer
4524  |  MTHFR  |  infer
394263  |  MUC21  |  infer
10  |  NAT2  |  infer
4790  |  NFKB1  |  infer
4792  |  NFKBIA  |  infer
64127  |  NOD2  |  infer
4843  |  NOS2  |  infer
4855  |  NOTCH4  |  infer
1728  |  NQO1  |  infer
5089  |  PBX2  |  infer
5266  |  PI3  |  infer
5460  |  POU5F1  |  infer
5465  |  PPARA  |  infer
5468  |  PPARG  |  infer
5491  |  PPIAP9  |  infer
5687  |  PSMA6  |  infer
5696  |  PSMB8  |  infer
5698  |  PSMB9  |  infer
170679  |  PSORS1C1  |  infer
170680  |  PSORS1C2  |  infer
100130889  |  PSORS1C3  |  infer
63870  |  PSORS5  |  infer
63869  |  PSORS6  |  infer
26191  |  PTPN22  |  infer
9232  |  PTTG1  |  infer
5966  |  REL  |  infer
5980  |  REV3L  |  infer
6048  |  RNF5  |  infer
100270953  |  RPL21P33  |  infer
116935  |  RPL3P2  |  infer
6231  |  RPS26  |  infer
861  |  RUNX1  |  infer
6256  |  RXRA  |  infer
6257  |  RXRB  |  infer
6273  |  S100A2  |  infer
6304  |  SATB1  |  infer
6385  |  SDC4  |  infer
5265  |  SERPINA1  |  infer
5271  |  SERPINB8  |  infer
6583  |  SLC22A4  |  infer
6584  |  SLC22A5  |  infer
6532  |  SLC6A4  |  infer
9368  |  SLC9A3R1  |  infer
9825  |  SPATA2  |  infer
6773  |  STAT2  |  infer
6775  |  STAT4  |  infer
387082  |  SUMO4  |  infer
6890  |  TAP1  |  infer
6891  |  TAP2  |  infer
6941  |  TCF19  |  infer
7040  |  TGFB1  |  infer
7124  |  TNF  |  infer
7128  |  TNFAIP3  |  infer
10318  |  TNIP1  |  infer
7148  |  TNXB  |  infer
10758  |  TRAF3IP2  |  infer
89870  |  TRIM15  |  infer
11074  |  TRIM31  |  infer
135644  |  TRIM40  |  infer
7248  |  TSC1  |  infer
7297  |  TYK2  |  infer
134510  |  UBLCP1  |  infer
7421  |  VDR  |  infer
7422  |  VEGFA  |  infer
387122  |  WASF5P  |  infer
221527  |  ZBTB12  |  infer
7707  |  ZNF148  |  infer
125893  |  ZNF816  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:727)
6362  |  CCL18  |  DISEASES
6376  |  CX3CL1  |  DISEASES
8993  |  PGLYRP1  |  DISEASES
6894  |  TARBP1  |  DISEASES
3385  |  ICAM3  |  DISEASES
64063  |  PRSS22  |  DISEASES
7132  |  TNFRSF1A  |  DISEASES
3861  |  KRT14  |  DISEASES
80341  |  BPIFB2  |  DISEASES
4804  |  NGFR  |  DISEASES
30009  |  TBX21  |  DISEASES
6583  |  SLC22A4  |  DISEASES
7051  |  TGM1  |  DISEASES
23411  |  SIRT1  |  DISEASES
6300  |  MAPK12  |  DISEASES
4282  |  MIF  |  DISEASES
5008  |  OSM  |  DISEASES
5594  |  MAPK1  |  DISEASES
3956  |  LGALS1  |  DISEASES
3162  |  HMOX1  |  DISEASES
158  |  ADSL  |  DISEASES
1511  |  CTSG  |  DISEASES
3002  |  GZMB  |  DISEASES
9517  |  SPTLC2  |  DISEASES
4792  |  NFKBIA  |  DISEASES
1591  |  CYP24A1  |  DISEASES
54941  |  RNF125  |  DISEASES
51311  |  TLR8  |  DISEASES
7076  |  TIMP1  |  DISEASES
4313  |  MMP2  |  DISEASES
6367  |  CCL22  |  DISEASES
1723  |  DHODH  |  DISEASES
6361  |  CCL17  |  DISEASES
5432  |  POLR2C  |  DISEASES
23269  |  MGA  |  DISEASES
9333  |  TGM5  |  DISEASES
5327  |  PLAT  |  DISEASES
8797  |  TNFRSF10A  |  DISEASES
56729  |  RETN  |  DISEASES
23581  |  CASP14  |  DISEASES
7040  |  TGFB1  |  DISEASES
973  |  CD79A  |  DISEASES
4818  |  NKG7  |  DISEASES
84518  |  CNFN  |  DISEASES
1311  |  COMP  |  DISEASES
5444  |  PON1  |  DISEASES
10135  |  NAMPT  |  DISEASES
5919  |  RARRES2  |  DISEASES
1592  |  CYP26A1  |  DISEASES
6348  |  CCL3  |  DISEASES
4353  |  MPO  |  DISEASES
1440  |  CSF3  |  DISEASES
6347  |  CCL2  |  DISEASES
6346  |  CCL1  |  DISEASES
6357  |  CCL13  |  DISEASES
4790  |  NFKB1  |  DISEASES
3558  |  IL2  |  DISEASES
595  |  CCND1  |  DISEASES
329  |  BIRC2  |  DISEASES
969  |  CD69  |  DISEASES
6404  |  SELPLG  |  DISEASES
51561  |  IL23A  |  DISEASES
1594  |  CYP27B1  |  DISEASES
55801  |  IL26  |  DISEASES
3458  |  IFNG  |  DISEASES
3820  |  KLRB1  |  DISEASES
1432  |  MAPK14  |  DISEASES
1839  |  HBEGF  |  DISEASES
4015  |  LOX  |  DISEASES
3003  |  GZMK  |  DISEASES
3565  |  IL4  |  DISEASES
3567  |  IL5  |  DISEASES
5917  |  RARS  |  DISEASES
5947  |  RBP1  |  DISEASES
338  |  APOB  |  DISEASES
3554  |  IL1R1  |  DISEASES
4953  |  ODC1  |  DISEASES
5657  |  PRTN3  |  DISEASES
6402  |  SELL  |  DISEASES
1509  |  CTSD  |  DISEASES
335  |  APOA1  |  DISEASES
7128  |  TNFAIP3  |  DISEASES
83982  |  IFI27L2  |  DISEASES
8600  |  TNFSF11  |  DISEASES
51747  |  LUC7L3  |  DISEASES
4035  |  LRP1  |  DISEASES
5266  |  PI3  |  DISEASES
55905  |  RNF114  |  DISEASES
27189  |  IL17C  |  DISEASES
80352  |  RNF39  |  DISEASES
667  |  DST  |  DISEASES
2806  |  GOT2  |  DISEASES
3659  |  IRF1  |  DISEASES
718  |  C3  |  DISEASES
57152  |  SLURP1  |  DISEASES
79713  |  IGFLR1  |  DISEASES
1236  |  CCR7  |  DISEASES
26030  |  PLEKHG3  |  DISEASES
391013  |  PLA2G2C  |  DISEASES
7538  |  ZFP36  |  DISEASES
968  |  CD68  |  DISEASES
6351  |  CCL4  |  DISEASES
1215  |  CMA1  |  DISEASES
3630  |  INS  |  DISEASES
239  |  ALOX12  |  DISEASES
79977  |  GRHL2  |  DISEASES
29775  |  CARD10  |  DISEASES
4277  |  MICB  |  DISEASES
3852  |  KRT5  |  DISEASES
3848  |  KRT1  |  DISEASES
9119  |  KRT75  |  DISEASES
348  |  APOE  |  DISEASES
684  |  BST2  |  DISEASES
6155  |  RPL27  |  DISEASES
3866  |  KRT15  |  DISEASES
84674  |  CARD6  |  DISEASES
1401  |  CRP  |  DISEASES
1116  |  CHI3L1  |  DISEASES
5920  |  RARRES3  |  DISEASES
4922  |  NTS  |  DISEASES
51124  |  IER3IP1  |  DISEASES
59340  |  HRH4  |  DISEASES
1828  |  DSG1  |  DISEASES
1823  |  DSC1  |  DISEASES
3891  |  KRT85  |  DISEASES
9958  |  USP15  |  DISEASES
80896  |  NPL  |  DISEASES
3569  |  IL6  |  DISEASES
56300  |  IL36G  |  DISEASES
3557  |  IL1RN  |  DISEASES
27179  |  IL36A  |  DISEASES
26525  |  IL36RN  |  DISEASES
5004  |  ORM1  |  DISEASES
10850  |  CCL27  |  DISEASES
170680  |  PSORS1C2  |  DISEASES
170679  |  PSORS1C1  |  DISEASES
5460  |  POU5F1  |  DISEASES
3134  |  HLA-F  |  DISEASES
7097  |  TLR2  |  DISEASES
10068  |  IL18BP  |  DISEASES
7057  |  THBS1  |  DISEASES
9360  |  PPIG  |  DISEASES
4069  |  LYZ  |  DISEASES
999  |  CDH1  |  DISEASES
27190  |  IL17B  |  DISEASES
9252  |  RPS6KA5  |  DISEASES
9172  |  MYOM2  |  DISEASES
3595  |  IL12RB2  |  DISEASES
9368  |  SLC9A3R1  |  DISEASES
5465  |  PPARA  |  DISEASES
5595  |  MAPK3  |  DISEASES
3682  |  ITGAE  |  DISEASES
23523  |  CABIN1  |  DISEASES
27178  |  IL37  |  DISEASES
3552  |  IL1A  |  DISEASES
3553  |  IL1B  |  DISEASES
10994  |  ILVBL  |  DISEASES
1991  |  ELANE  |  DISEASES
64135  |  IFIH1  |  DISEASES
6403  |  SELP  |  DISEASES
9917  |  FAM20B  |  DISEASES
3574  |  IL7  |  DISEASES
10578  |  GNLY  |  DISEASES
3791  |  KDR  |  DISEASES
943  |  TNFRSF8  |  DISEASES
4162  |  MCAM  |  DISEASES
10382  |  TUBB4A  |  DISEASES
8540  |  AGPS  |  DISEASES
8942  |  KYNU  |  DISEASES
941  |  CD80  |  DISEASES
8808  |  IL1RL2  |  DISEASES
8807  |  IL18RAP  |  DISEASES
1475  |  CSTA  |  DISEASES
374  |  AREG  |  DISEASES
59067  |  IL21  |  DISEASES
2247  |  FGF2  |  DISEASES
3589  |  IL11  |  DISEASES
7474  |  WNT5A  |  DISEASES
6774  |  STAT3  |  DISEASES
2255  |  FGF10  |  DISEASES
5443  |  POMC  |  DISEASES
2355  |  FOSL2  |  DISEASES
7297  |  TYK2  |  DISEASES
3383  |  ICAM1  |  DISEASES
53371  |  NUP54  |  DISEASES
3827  |  KNG1  |  DISEASES
6897  |  TARS  |  DISEASES
259  |  AMBP  |  DISEASES
1950  |  EGF  |  DISEASES
10371  |  SEMA3A  |  DISEASES
1390  |  CREM  |  DISEASES
4258  |  MGST2  |  DISEASES
27074  |  LAMP3  |  DISEASES
7078  |  TIMP3  |  DISEASES
939  |  CD27  |  DISEASES
2252  |  FGF7  |  DISEASES
3687  |  ITGAX  |  DISEASES
6687  |  SPG7  |  DISEASES
7157  |  TP53  |  DISEASES
79755  |  ZNF750  |  DISEASES
3858  |  KRT10  |  DISEASES
207  |  AKT1  |  DISEASES
5141  |  PDE4A  |  DISEASES
58985  |  IL22RA1  |  DISEASES
2212  |  FCGR2A  |  DISEASES
6282  |  S100A11  |  DISEASES
805  |  CALM2  |  DISEASES
26018  |  LRIG1  |  DISEASES
3578  |  IL9  |  DISEASES
54901  |  CDKAL1  |  DISEASES
222663  |  SCUBE3  |  DISEASES
1956  |  EGFR  |  DISEASES
6770  |  STAR  |  DISEASES
1392  |  CRH  |  DISEASES
3439  |  IFNA1  |  DISEASES
3934  |  LCN2  |  DISEASES
4851  |  NOTCH1  |  DISEASES
85463  |  ZC3H12C  |  DISEASES
2206  |  MS4A2  |  DISEASES
7424  |  VEGFC  |  DISEASES
3606  |  IL18  |  DISEASES
7082  |  TJP1  |  DISEASES
5741  |  PTH  |  DISEASES
2321  |  FLT1  |  DISEASES
6317  |  SERPINB3  |  DISEASES
7345  |  UCHL1  |  DISEASES
152273  |  FGD5  |  DISEASES
55326  |  AGPAT5  |  DISEASES
135228  |  CD109  |  DISEASES
6750  |  SST  |  DISEASES
5468  |  PPARG  |  DISEASES
55540  |  IL17RB  |  DISEASES
57822  |  GRHL3  |  DISEASES
3242  |  HPD  |  DISEASES
9825  |  SPATA2  |  DISEASES
50651  |  SLC45A1  |  DISEASES
3588  |  IL10RB  |  DISEASES
57727  |  NCOA5  |  DISEASES
283748  |  PLA2G4D  |  DISEASES
114771  |  PGLYRP3  |  DISEASES
1636  |  ACE  |  DISEASES
808  |  CALM3  |  DISEASES
23547  |  LILRA4  |  DISEASES
6271  |  S100A1  |  DISEASES
729230  |  CCR2  |  DISEASES
1234  |  CCR5  |  DISEASES
150223  |  YDJC  |  DISEASES
6352  |  CCL5  |  DISEASES
117159  |  DCD  |  DISEASES
246  |  ALOX15  |  DISEASES
7412  |  VCAM1  |  DISEASES
2215  |  FCGR3B  |  DISEASES
5966  |  REL  |  DISEASES
83932  |  SPRTN  |  DISEASES
132671  |  SPATA18  |  DISEASES
27306  |  HPGDS  |  DISEASES
6707  |  SPRR3  |  DISEASES
9076  |  CLDN1  |  DISEASES
60675  |  PROK2  |  DISEASES
3577  |  CXCR1  |  DISEASES
152185  |  SPICE1  |  DISEASES
213  |  ALB  |  DISEASES
132014  |  IL17RE  |  DISEASES
84818  |  IL17RC  |  DISEASES
2921  |  CXCL3  |  DISEASES
6374  |  CXCL5  |  DISEASES
7349  |  UCN  |  DISEASES
7047  |  TGM4  |  DISEASES
1230  |  CCR1  |  DISEASES
3693  |  ITGB5  |  DISEASES
54756  |  IL17RD  |  DISEASES
308  |  ANXA5  |  DISEASES
132612  |  ADAD1  |  DISEASES
3600  |  IL15  |  DISEASES
134429  |  STARD4  |  DISEASES
51752  |  ERAP1  |  DISEASES
7098  |  TLR3  |  DISEASES
3562  |  IL3  |  DISEASES
1437  |  CSF2  |  DISEASES
116379  |  IL22RA2  |  DISEASES
2171  |  FABP5  |  DISEASES
4982  |  TNFRSF11B  |  DISEASES
1672  |  DEFB1  |  DISEASES
360  |  AQP3  |  DISEASES
84659  |  RNASE7  |  DISEASES
3429  |  IFI27  |  DISEASES
79789  |  CLMN  |  DISEASES
1381  |  CRABP1  |  DISEASES
4314  |  MMP3  |  DISEASES
290  |  ANPEP  |  DISEASES
6778  |  STAT6  |  DISEASES
861  |  RUNX1  |  DISEASES
254240  |  BPIFC  |  DISEASES
64127  |  NOD2  |  DISEASES
4218  |  RAB8A  |  DISEASES
3816  |  KLK1  |  DISEASES
3868  |  KRT16  |  DISEASES
5436  |  POLR2G  |  DISEASES
5617  |  PRL  |  DISEASES
6356  |  CCL11  |  DISEASES
9101  |  USP8  |  DISEASES
6037  |  RNASE3  |  DISEASES
598  |  BCL2L1  |  DISEASES
3479  |  IGF1  |  DISEASES
2990  |  GUSB  |  DISEASES
53342  |  IL17D  |  DISEASES
3603  |  IL16  |  DISEASES
3308  |  HSPA4  |  DISEASES
3689  |  ITGB2  |  DISEASES
3726  |  JUNB  |  DISEASES
3688  |  ITGB1  |  DISEASES
6869  |  TACR1  |  DISEASES
1673  |  DEFB4A  |  DISEASES
1493  |  CTLA4  |  DISEASES
3596  |  IL13  |  DISEASES
1901  |  S1PR1  |  DISEASES
1051  |  CEBPB  |  DISEASES
3627  |  CXCL10  |  DISEASES
114787  |  GPRIN1  |  DISEASES
3575  |  IL7R  |  DISEASES
2353  |  FOS  |  DISEASES
6699  |  SPRR1B  |  DISEASES
56246  |  MRAP  |  DISEASES
654483  |  BOLA2B  |  DISEASES
6373  |  CXCL11  |  DISEASES
57521  |  RPTOR  |  DISEASES
1241  |  LTB4R  |  DISEASES
195814  |  SDR16C5  |  DISEASES
29785  |  CYP2S1  |  DISEASES
3872  |  KRT17  |  DISEASES
6363  |  CCL19  |  DISEASES
81793  |  TLR10  |  DISEASES
5340  |  PLG  |  DISEASES
5653  |  KLK6  |  DISEASES
5222  |  PGA5  |  DISEASES
3265  |  HRAS  |  DISEASES
947  |  CD34  |  DISEASES
3661  |  IRF3  |  DISEASES
8061  |  FOSL1  |  DISEASES
6670  |  SP3  |  DISEASES
3849  |  KRT2  |  DISEASES
5467  |  PPARD  |  DISEASES
836  |  CASP3  |  DISEASES
1474  |  CST6  |  DISEASES
1240  |  CMKLR1  |  DISEASES
924  |  CD7  |  DISEASES
8639  |  AOC3  |  DISEASES
3952  |  LEP  |  DISEASES
245928  |  DEFB114  |  DISEASES
23166  |  STAB1  |  DISEASES
11322  |  TMC6  |  DISEASES
285  |  ANGPT2  |  DISEASES
53832  |  IL20RA  |  DISEASES
130367  |  SGPP2  |  DISEASES
242  |  ALOX12B  |  DISEASES
810  |  CALML3  |  DISEASES
30835  |  CD209  |  DISEASES
284207  |  METRNL  |  DISEASES
79966  |  SCD5  |  DISEASES
8560  |  DEGS1  |  DISEASES
1775  |  DNASE1L2  |  DISEASES
51268  |  PIPOX  |  DISEASES
10318  |  TNIP1  |  DISEASES
126638  |  RPTN  |  DISEASES
4684  |  NCAM1  |  DISEASES
158056  |  MAMDC4  |  DISEASES
3579  |  CXCR2  |  DISEASES
80381  |  CD276  |  DISEASES
170591  |  S100Z  |  DISEASES
9370  |  ADIPOQ  |  DISEASES
140596  |  DEFB104A  |  DISEASES
23765  |  IL17RA  |  DISEASES
414325  |  DEFB103A  |  DISEASES
6863  |  TAC1  |  DISEASES
4018  |  LPA  |  DISEASES
149233  |  IL23R  |  DISEASES
503618  |  DEFB104B  |  DISEASES
643834  |  PGA3  |  DISEASES
3039  |  HBA1  |  DISEASES
4312  |  MMP1  |  DISEASES
923  |  CD6  |  DISEASES
55600  |  ITLN1  |  DISEASES
2  |  A2M  |  DISEASES
55894  |  DEFB103B  |  DISEASES
9235  |  IL32  |  DISEASES
57010  |  CABP4  |  DISEASES
147138  |  TMC8  |  DISEASES
64332  |  NFKBIZ  |  DISEASES
9622  |  KLK4  |  DISEASES
1237  |  CCR8  |  DISEASES
51330  |  TNFRSF12A  |  DISEASES
6097  |  RORC  |  DISEASES
4843  |  NOS2  |  DISEASES
339366  |  ADAMTSL5  |  DISEASES
4772  |  NFATC1  |  DISEASES
3563  |  IL3RA  |  DISEASES
388121  |  TNFAIP8L3  |  DISEASES
64806  |  IL25  |  DISEASES
53833  |  IL20RB  |  DISEASES
8784  |  TNFRSF18  |  DISEASES
10456  |  HAX1  |  DISEASES
338324  |  S100A7A  |  DISEASES
50616  |  IL22  |  DISEASES
8651  |  SOCS1  |  DISEASES
51350  |  KRT76  |  DISEASES
9021  |  SOCS3  |  DISEASES
552900  |  BOLA2  |  DISEASES
5271  |  SERPINB8  |  DISEASES
6401  |  SELE  |  DISEASES
942  |  CD86  |  DISEASES
5142  |  PDE4B  |  DISEASES
2826  |  CCR10  |  DISEASES
9939  |  RBM8A  |  DISEASES
8986  |  RPS6KA4  |  DISEASES
254910  |  LCE5A  |  DISEASES
57178  |  ZMIZ1  |  DISEASES
353144  |  LCE3C  |  DISEASES
353142  |  LCE3A  |  DISEASES
5133  |  PDCD1  |  DISEASES
353143  |  LCE3B  |  DISEASES
3802  |  KIR2DL1  |  DISEASES
9765  |  ZFYVE16  |  DISEASES
114548  |  NLRP3  |  DISEASES
112744  |  IL17F  |  DISEASES
25818  |  KLK5  |  DISEASES
66004  |  LYNX1  |  DISEASES
3091  |  HIF1A  |  DISEASES
3824  |  KLRD1  |  DISEASES
5269  |  SERPINB6  |  DISEASES
84896  |  ATAD1  |  DISEASES
388533  |  KRTDAP  |  DISEASES
1235  |  CCR6  |  DISEASES
3117  |  HLA-DQA1  |  DISEASES
85480  |  TSLP  |  DISEASES
4602  |  MYB  |  DISEASES
3329  |  HSPD1  |  DISEASES
1308  |  COL17A1  |  DISEASES
126364  |  LRRC25  |  DISEASES
285343  |  TCAIM  |  DISEASES
5275  |  SERPINB13  |  DISEASES
84419  |  C15orf48  |  DISEASES
84639  |  IL1F10  |  DISEASES
6590  |  SLPI  |  DISEASES
145264  |  SERPINA12  |  DISEASES
3804  |  KIR2DL3  |  DISEASES
4939  |  OAS2  |  DISEASES
29949  |  IL19  |  DISEASES
3716  |  JAK1  |  DISEASES
6318  |  SERPINB4  |  DISEASES
864  |  RUNX3  |  DISEASES
257101  |  ZNF683  |  DISEASES
3605  |  IL17A  |  DISEASES
1499  |  CTNNB1  |  DISEASES
79092  |  CARD14  |  DISEASES
128859  |  BPIFB6  |  DISEASES
9232  |  PTTG1  |  DISEASES
538  |  ATP7A  |  DISEASES
114770  |  PGLYRP2  |  DISEASES
309  |  ANXA6  |  DISEASES
100506658  |  OCLN  |  DISEASES
5265  |  SERPINA1  |  DISEASES
3240  |  HP  |  DISEASES
80332  |  ADAM33  |  DISEASES
283234  |  CCDC88B  |  DISEASES
3683  |  ITGAL  |  DISEASES
801  |  CALM1  |  DISEASES
9034  |  CCRL2  |  DISEASES
125893  |  ZNF816  |  DISEASES
26151  |  NAT9  |  DISEASES
163227  |  ZNF100  |  DISEASES
1524  |  CX3CR1  |  DISEASES
6775  |  STAT4  |  DISEASES
26010  |  SPATS2L  |  DISEASES
2526  |  FUT4  |  DISEASES
6364  |  CCL20  |  DISEASES
5139  |  PDE3A  |  DISEASES
3821  |  KLRC1  |  DISEASES
9332  |  CD163  |  DISEASES
57115  |  PGLYRP4  |  DISEASES
26191  |  PTPN22  |  DISEASES
387129  |  NPSR1  |  DISEASES
11005  |  SPINK5  |  DISEASES
3123  |  HLA-DRB1  |  DISEASES
3135  |  HLA-G  |  DISEASES
5599  |  MAPK8  |  DISEASES
170482  |  CLEC4C  |  DISEASES
1803  |  DPP4  |  DISEASES
54106  |  TLR9  |  DISEASES
6772  |  STAT1  |  DISEASES
460  |  ASTN1  |  DISEASES
2475  |  MTOR  |  DISEASES
7855  |  FZD5  |  DISEASES
4283  |  CXCL9  |  DISEASES
4215  |  MAP3K3  |  DISEASES
7096  |  TLR1  |  DISEASES
7052  |  TGM2  |  DISEASES
117289  |  TAGAP  |  DISEASES
6993  |  DYNLT1  |  DISEASES
7432  |  VIP  |  DISEASES
5788  |  PTPRC  |  DISEASES
10090  |  UST  |  DISEASES
5743  |  PTGS2  |  DISEASES
51696  |  HECA  |  DISEASES
9287  |  TAAR2  |  DISEASES
2214  |  FCGR3A  |  DISEASES
51744  |  CD244  |  DISEASES
383  |  ARG1  |  DISEASES
9447  |  AIM2  |  DISEASES
911  |  CD1C  |  DISEASES
912  |  CD1D  |  DISEASES
1382  |  CRABP2  |  DISEASES
3570  |  IL6R  |  DISEASES
4288  |  MKI67  |  DISEASES
6273  |  S100A2  |  DISEASES
6274  |  S100A3  |  DISEASES
6278  |  S100A7  |  DISEASES
6279  |  S100A8  |  DISEASES
6283  |  S100A12  |  DISEASES
6280  |  S100A9  |  DISEASES
4014  |  LOR  |  DISEASES
574414  |  PRR9  |  DISEASES
10758  |  TRAF3IP2  |  DISEASES
3713  |  IVL  |  DISEASES
26239  |  LCE2B  |  DISEASES
84648  |  LCE3D  |  DISEASES
353145  |  LCE3E  |  DISEASES
2312  |  FLG  |  DISEASES
388697  |  HRNR  |  DISEASES
7062  |  TCHH  |  DISEASES
126637  |  TCHHL1  |  DISEASES
6281  |  S100A10  |  DISEASES
4942  |  OAT  |  DISEASES
1520  |  CTSS  |  DISEASES
25957  |  PNISR  |  DISEASES
914  |  CD2  |  DISEASES
965  |  CD58  |  DISEASES
4803  |  NGF  |  DISEASES
3738  |  KCNA3  |  DISEASES
2316  |  FLNA  |  DISEASES
3654  |  IRAK1  |  DISEASES
163351  |  GBP6  |  DISEASES
55257  |  MRGBP  |  DISEASES
959  |  CD40LG  |  DISEASES
400757  |  C1orf141  |  DISEASES
1791  |  DNTT  |  DISEASES
3725  |  JUN  |  DISEASES
5950  |  RBP4  |  DISEASES
7422  |  VEGFA  |  DISEASES
387695  |  C10orf99  |  DISEASES
958  |  CD40  |  DISEASES
729238  |  SFTPA2  |  DISEASES
4318  |  MMP9  |  DISEASES
80149  |  ZC3H12A  |  DISEASES
9436  |  NCR2  |  DISEASES
83931  |  STK40  |  DISEASES
2833  |  CXCR3  |  DISEASES
51645  |  PPIL1  |  DISEASES
22839  |  DLGAP4  |  DISEASES
7099  |  TLR4  |  DISEASES
9966  |  TNFSF15  |  DISEASES
240  |  ALOX5  |  DISEASES
9314  |  KLF4  |  DISEASES
3108  |  HLA-DMA  |  DISEASES
3127  |  HLA-DRB5  |  DISEASES
64600  |  PLA2G2F  |  DISEASES
26279  |  PLA2G2D  |  DISEASES
30814  |  PLA2G2E  |  DISEASES
3376  |  IARS  |  DISEASES
4795  |  NFKBIL1  |  DISEASES
50943  |  FOXP3  |  DISEASES
100507436  |  MICA  |  DISEASES
3107  |  HLA-C  |  DISEASES
6941  |  TCF19  |  DISEASES
7133  |  TNFRSF1B  |  DISEASES
1041  |  CDSN  |  DISEASES
4524  |  MTHFR  |  DISEASES
2794  |  GNL1  |  DISEASES
3105  |  HLA-A  |  DISEASES
386653  |  IL31  |  DISEASES
3604  |  TNFRSF9  |  DISEASES
4609  |  MYC  |  DISEASES
643847  |  PGA4  |  DISEASES
51131  |  PHF11  |  DISEASES
57380  |  MRS2  |  DISEASES
8559  |  PRPF18  |  DISEASES
1536  |  CYBB  |  DISEASES
9308  |  CD83  |  DISEASES
2625  |  GATA3  |  DISEASES
1906  |  EDN1  |  DISEASES
9636  |  ISG15  |  DISEASES
10186  |  LHFP  |  DISEASES
23586  |  DDX58  |  DISEASES
3559  |  IL2RA  |  DISEASES
3853  |  KRT6A  |  DISEASES
7010  |  TEK  |  DISEASES
79886  |  CAAP1  |  DISEASES
247  |  ALOX15B  |  DISEASES
3456  |  IFNB1  |  DISEASES
54620  |  FBXL19  |  DISEASES
140462  |  ASB9  |  DISEASES
241  |  ALOX5AP  |  DISEASES
51284  |  TLR7  |  DISEASES
11168  |  PSIP1  |  DISEASES
1992  |  SERPINB1  |  DISEASES
3486  |  IGFBP3  |  DISEASES
347527  |  ARSH  |  DISEASES
90865  |  IL33  |  DISEASES
7053  |  TGM3  |  DISEASES
53919  |  SLCO1C1  |  DISEASES
29126  |  CD274  |  DISEASES
3717  |  JAK2  |  DISEASES
3822  |  KLRC2  |  DISEASES
50834  |  TAS2R1  |  DISEASES
2706  |  GJB2  |  DISEASES
645840  |  TXNRD3NB  |  DISEASES
11202  |  KLK8  |  DISEASES
5650  |  KLK7  |  DISEASES
11009  |  IL24  |  DISEASES
55054  |  ATG16L1  |  DISEASES
124599  |  CD300LB  |  DISEASES
122509  |  IFI27L1  |  DISEASES
838  |  CASP5  |  DISEASES
27032  |  ATP2C1  |  DISEASES
84561  |  SLC12A8  |  DISEASES
3660  |  IRF2  |  DISEASES
5627  |  PROS1  |  DISEASES
140467  |  ZNF358  |  DISEASES
9560  |  CCL4L2  |  DISEASES
6696  |  SPP1  |  DISEASES
3122  |  HLA-DRA  |  DISEASES
2919  |  CXCL1  |  DISEASES
6387  |  CXCL12  |  DISEASES
4773  |  NFATC2  |  DISEASES
54535  |  CCHCR1  |  DISEASES
6202  |  RPS8  |  DISEASES
130340  |  AP1S3  |  DISEASES
84433  |  CARD11  |  DISEASES
3269  |  HRH1  |  DISEASES
5609  |  MAP2K7  |  DISEASES
594857  |  NPS  |  DISEASES
8608  |  RDH16  |  DISEASES
1394  |  CRHR1  |  DISEASES
4599  |  MX1  |  DISEASES
7442  |  TRPV1  |  DISEASES
5970  |  RELA  |  DISEASES
339263  |  C17orf51  |  DISEASES
2825  |  GPR1  |  DISEASES
223075  |  CCDC129  |  DISEASES
5150  |  PDE7A  |  DISEASES
50489  |  CD207  |  DISEASES
501  |  ALDH7A1  |  DISEASES
2641  |  GCG  |  DISEASES
10093  |  ARPC4  |  DISEASES
3384  |  ICAM2  |  DISEASES
3718  |  JAK3  |  DISEASES
197  |  AHSG  |  DISEASES
1029  |  CDKN2A  |  DISEASES
720  |  C4A  |  DISEASES
64282  |  PAPD5  |  DISEASES
10107  |  TRIM10  |  DISEASES
653509  |  SFTPA1  |  DISEASES
57511  |  COG6  |  DISEASES
960  |  CD44  |  DISEASES
7124  |  TNF  |  DISEASES
3491  |  CYR61  |  DISEASES
3106  |  HLA-B  |  DISEASES
64167  |  ERAP2  |  DISEASES
4615  |  MYD88  |  DISEASES
3594  |  IL12RB1  |  DISEASES
4049  |  LTA  |  DISEASES
388372  |  CCL4L1  |  DISEASES
3115  |  HLA-DPB1  |  DISEASES
6349  |  CCL3L1  |  DISEASES
1154  |  CISH  |  DISEASES
23228  |  PLCL2  |  DISEASES
79897  |  RPP21  |  DISEASES
834  |  CASP1  |  DISEASES
4050  |  LTB  |  DISEASES
3586  |  IL10  |  DISEASES
10665  |  C6orf10  |  DISEASES
374918  |  IGFL1  |  DISEASES
721  |  C4B  |  DISEASES
4753  |  NELL2  |  DISEASES
143662  |  MUC15  |  DISEASES
4700  |  NDUFA6  |  DISEASES
5478  |  PPIA  |  DISEASES
56244  |  BTNL2  |  DISEASES
6949  |  TCOF1  |  DISEASES
2638  |  GC  |  DISEASES
51428  |  DDX41  |  DISEASES
10744  |  PTTG2  |  DISEASES
100289462  |  DEFB4B  |  DISEASES
2920  |  CXCL2  |  DISEASES
3551  |  IKBKB  |  DISEASES
4914  |  NTRK1  |  DISEASES
123041  |  SLC24A4  |  DISEASES
1207  |  CLNS1A  |  DISEASES
59082  |  CARD18  |  DISEASES
930  |  CD19  |  DISEASES
387357  |  THEMIS  |  DISEASES
488  |  ATP2A2  |  DISEASES
55350  |  VNN3  |  DISEASES
57655  |  GRAMD1A  |  DISEASES
64478  |  CSMD1  |  DISEASES
3684  |  ITGAM  |  DISEASES
23312  |  DMXL2  |  DISEASES
11331  |  PHB2  |  DISEASES
55922  |  NKRF  |  DISEASES
7421  |  VDR  |  DISEASES
319089  |  TTC6  |  DISEASES
8742  |  TNFSF12  |  DISEASES
567  |  B2M  |  DISEASES
253018  |  HCG27  |  DISEASES
9728  |  SECISBP2L  |  DISEASES
100507679  |  MUC22  |  DISEASES
820  |  CAMP  |  DISEASES
1506  |  CTRL  |  DISEASES
22861  |  NLRP1  |  DISEASES
10040  |  TOM1L1  |  DISEASES
199777  |  ZNF626  |  DISEASES
10255  |  HCG9  |  DISEASES
10866  |  HCP5  |  DISEASES
100885779  |  LINC-ROR  |  DISEASES
404744  |  NPSR1-AS1  |  DISEASES
100861550  |  PDX1-AS1  |  DISEASES
100169750  |  PRINS  |  DISEASES
100130889  |  PSORS1C3  |  DISEASES
Locus(Waiting for update.)
Disease ID 64
Disease psoriasis
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:126)
HP:0001369  |  Arthritis  |  76
HP:0001513  |  Obesity  |  29
HP:0000716  |  Depression  |  23
HP:0000822  |  Hypertension  |  14
HP:0000989  |  pruritis  |  13
HP:0002664  |  Neoplasia  |  12
HP:0012115  |  Liver inflammation  |  10
HP:0003040  |  Arthropathy  |  10
HP:0010783  |  Erythema  |  9
HP:0002621  |  Atherosclerosis  |  9
HP:0002960  |  Autoimmune condition  |  8
HP:0001658  |  Myocardial infarction  |  7
HP:0030731  |  Carcinoma  |  6
HP:0001297  |  Cerebral vascular events  |  6
HP:0000739  |  Anxiety  |  6
HP:0002860  |  Squamous cell carcinoma  |  5
HP:0001677  |  Coronary artery disease  |  5
HP:0012531  |  Pain  |  5
HP:0000855  |  Insulin resistance  |  5
HP:0012203  |  Onychomycosis  |  5
HP:0001596  |  Hair loss  |  5
HP:0001047  |  Atopic dermatitis  |  5
HP:0000704  |  Pyorrhea  |  4
HP:0100280  |  Morbus Crohn  |  4
HP:0003077  |  Hyperlipidemia  |  4
HP:0100686  |  Enthesitis  |  4
HP:0000819  |  Diabetes mellitus  |  4
HP:0001370  |  Rheumatoid arthritis  |  4
HP:0002665  |  Lymphoma  |  3
HP:0003074  |  High blood glucose  |  3
HP:0040154  |  Hidradenitis suppurativa  |  3
HP:0000964  |  Eczema  |  3
HP:0012378  |  Fatigue  |  3
HP:0000083  |  Renal insufficiency  |  3
HP:0005110  |  Atrial fibrillation  |  3
HP:0001907  |  Thromboembolic disease  |  3
HP:0011123  |  Skin inflammation  |  3
HP:0001036  |  Parakeratosis  |  3
HP:0002725  |  Systemic lupus erythematosus  |  2
HP:0003124  |  Elevated serum cholesterol  |  2
HP:0001395  |  Hepatic fibrosis  |  2
HP:0001717  |  Coronary artery calcification  |  2
HP:0001638  |  Cardiomyopathy  |  2
HP:0100512  |  Vitamin D deficiency  |  2
HP:0000554  |  Uveitis  |  2
HP:0002099  |  Asthma  |  2
HP:0100769  |  Synovitis  |  2
HP:0001824  |  Weight loss  |  2
HP:0001019  |  Exfoliative dermititis  |  2
HP:0001045  |  Blotchy loss of skin color  |  2
HP:0000962  |  Hyperkeratosis  |  2
HP:0100242  |  Sarcoma  |  2
HP:0200039  |  Pustules  |  2
HP:0000708  |  Behavioral problems  |  2
HP:0005187  |  Progressive joint destruction  |  1
HP:0001581  |  Recurrent skin infections  |  1
HP:0012126  |  Gastric cancer  |  1
HP:0002749  |  Osteomalacia  |  1
HP:0000572  |  Visual loss  |  1
HP:0001901  |  Abnormally shaped erythrocytes  |  1
HP:0000802  |  Erectile dysfunction  |  1
HP:0001010  |  Hypopigmentation of the skin  |  1
HP:0002360  |  Sleep disturbance  |  1
HP:0002895  |  Papillary thyroid carcinoma  |  1
HP:0000969  |  Dropsy  |  1
HP:0012743  |  Central obesity  |  1
HP:0030016  |  Dyspareunia  |  1
HP:0001072  |  Pachydermia  |  1
HP:0008653  |  Crescentic glomerulonephritis  |  1
HP:0030151  |  Cholangitis  |  1
HP:0011034  |  Amyloid disease  |  1
HP:0001880  |  Eosinophilia  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0012740  |  Papilloma  |  1
HP:0004416  |  Precocious atherosclerosis  |  1
HP:0012190  |  T cell lymphoma  |  1
HP:0000975  |  Increased sweating  |  1
HP:0002719  |  infections, recurrent  |  1
HP:0001735  |  Acute pancreatitis  |  1
HP:0003761  |  Calcinosis  |  1
HP:0002633  |  Vasculitis  |  1
HP:0001397  |  Hepatic steatosis  |  1
HP:0001873  |  Low platelet count  |  1
HP:0005584  |  Renal cell carcinoma  |  1
HP:0006280  |  Chronic pancreas inflammation  |  1
HP:0000722  |  Obsessive compulsive disorder  |  1
HP:0030242  |  Blood clot in portal vein  |  1
HP:0040189  |  Desquamation  |  1
HP:0002721  |  Immunodeficiency  |  1
HP:0002890  |  Thyroid carcinoma  |  1
HP:0001025  |  Hives  |  1
HP:0005681  |  Juvenile idiopathic arthritis  |  1
HP:0100550  |  Rupture of tendons  |  1
HP:0005435  |  Impaired T cell function  |  1
HP:0003193  |  Allergic rhinitis  |  1
HP:0001004  |  Lymphatic obstruction  |  1
HP:0002829  |  Arthralgias  |  1
HP:0200034  |  Papule  |  1
HP:0200043  |  Verrucae  |  1
HP:0008404  |  Dystrophic nails  |  1
HP:0001644  |  Congestive cardiomyopathy  |  1
HP:0100726  |  Kaposi's sarcoma  |  1
HP:0002861  |  Melanoma  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0000939  |  Osteoporosis  |  1
HP:0100699  |  Scarring  |  1
HP:0000099  |  Glomerular nephritis  |  1
HP:0001997  |  Gout  |  1
HP:0000958  |  Xerosis  |  1
HP:0001894  |  Thrombocytosis  |  1
HP:0012622  |  Chronic kidney disease  |  1
HP:0009775  |  Amniotic constriction ring  |  1
HP:0003493  |  Elevated antinuclear antibody  |  1
HP:0007430  |  Generalized edema  |  1
HP:0011110  |  Inflammation of tonsils  |  1
HP:0000166  |  Severe periodontal disease  |  1
HP:0006562  |  Viral hepatitis  |  1
HP:0100825  |  Inflammation of the lips  |  1
HP:0010834  |  Trophic changes  |  1
HP:0001945  |  Fever  |  1
HP:0200123  |  Chronic liver inflammation  |  1
HP:0001733  |  Pancreatic inflammation  |  1
HP:0200119  |  Acute liver inflammation  |  1
HP:0002608  |  Celiac disease  |  1
HP:0003473  |  Fatigable weakness  |  1
HP:0006775  |  Multiple myeloma  |  1
Disease ID 64
Disease psoriasis
Manually Symptom
UMLS  | Name(Total Manually Symptoms:231)
C2707258  |  infections
C2697391  |  rheumatoid arthritis
C2598155  |  pain
C2364133  |  infection
C2364072  |  depression
C2364050  |  hypothermia
C2186532  |  liver disease
C1963266  |  uveitis
C1963220  |  pulmonary hypertension
C1963185  |  obesity
C1963138  |  hypertension
C1963066  |  joint pain
C1963064  |  anxiety
C1962983  |  cataract
C1962967  |  retinoic acid syndrome
C1867449  |  psors1
C1863767  |  m syndrome
C1853959  |  birdshot chorioretinopathy
C1744558  |  t-lymphocyte deficiency
C1737229  |  pemphigus herpetiformis
C1705714  |  warts
C1627366  |  abrasion
C1623038  |  cirrhosis
C1611280  |  allergy
C1555754  |  cardiovascular disease
C1547219  |  basal cell carcinoma
C1512411  |  hepatocellular carcinoma
C1456793  |  echinococcus granulosus
C1397910  |  furfur
C1393529  |  vascular complications
C1373218  |  immunosuppression
C1335115  |  adenocarcinoma of the mouth
C1301700  |  cardiovascular morbidity
C1301362  |  primary cutaneous cd30+ large t-cell lymphoma
C1290886  |  chronic inflammatory disease
C1290884  |  inflammatory disorder
C1145628  |  autonomic nervous system disorders
C1000587  |  pemphigus
C0949690  |  spinal arthritis
C0948265  |  metabolic syndrome
C0870082  |  skin hyperkeratosis
C0858970  |  carcinogenicity
C0849640  |  skin damage
C0796561  |  melanoma
C0740394  |  hyperuricemia
C0730328  |  central serous chorioretinopathy
C0702102  |  arthritis mutilans
C0700361  |  distress
C0699893  |  skin carcinoma
C0699893  |  nonmelanoma skin cancer
C0699893  |  carcinoma of the skin
C0683381  |  inflammatory joint disease
C0600327  |  toxic shock syndrome
C0586407  |  skin symptoms
C0574960  |  sacroiliitis
C0549622  |  sexual dysfunction
C0521607  |  peritoneal fibrosis
C0473574  |  inflammatory linear verrucous epidermal nevus
C0406352  |  tripe palms
C0400822  |  lymphocytic colitis
C0376293  |  stigmata
C0348754  |  hepatotoxicity
C0342622  |  amyloid arthropathy
C0333992  |  clear cell acanthoma
C0332790  |  bony ankylosis
C0281479  |  systemic amyloidosis
C0274306  |  cutaneous anaphylaxis
C0271650  |  glucose intolerance
C0268397  |  amyloidosis cutis
C0268382  |  renal amyloidosis
C0268087  |  chronic zinc deficiency
C0264005  |  eosinophilic fasciitis
C0263933  |  achilles tendinitis
C0263449  |  perioral dermatitis
C0263367  |  koebner phenomenon
C0263367  |  kobner phenomenon
C0263367  |  isomorphic response
C0263313  |  pemphigus foliaceus
C0262988  |  cutaneous vasculitis
C0242490  |  enthesopathy
C0242490  |  enthesopathies
C0239946  |  liver fibrosis
C0239946  |  hepatic fibrosis
C0238348  |  squamous cell carcinoma of the penis
C0235267  |  red eye
C0235162  |  sleep difficulties
C0233401  |  psychiatric symptoms
C0233397  |  psychological symptoms
C0221260  |  nail dystrophy
C0221260  |  nail dystrophies
C0221232  |  wheal
C0221014  |  secondary amyloidosis
C0220847  |  hepatitis c
C0206139  |  oral lichen planus
C0162851  |  pityriasis lichenoides chronica
C0162820  |  allergic contact dermatitis
C0162678  |  neurofibromatosis
C0162323  |  polyarthritis
C0155339  |  brown syndrome
C0155091  |  corneal abscess
C0154251  |  disorders of lipid metabolism
C0153676  |  lung metastases
C0149985  |  secondary syphilis
C0149670  |  disorders of carbohydrate metabolism
C0086873  |  scarring alopecia
C0086132  |  depressive symptoms
C0085580  |  essential hypertension
C0079772  |  t-cell lymphoma
C0079731  |  b-cell lymphoma
C0079173  |  craniomandibular disorders
C0078048  |  varicella
C0062527  |  hepatitis b
C0042769  |  virus infection
C0042373  |  vascular disorders
C0042373  |  vascular diseases
C0042373  |  vascular disease
C0042170  |  vogt-koyanagi-harada syndrome
C0041834  |  red skin
C0041834  |  erythema
C0041408  |  turner's syndrome
C0041296  |  tuberculosis
C0040261  |  tinea unguium
C0040261  |  onychomycosis
C0040259  |  tinea pedis
C0040128  |  thyroid disorders
C0039520  |  tenosynovitis
C0039494  |  temporomandibular disorders
C0039128  |  syphilis
C0039103  |  synovitis
C0038454  |  stroke
C0038358  |  gastric ulcer
C0038013  |  ankylosing spondylitis
C0038012  |  spondylitis
C0037286  |  skin tumors
C0037285  |  skin manifestations
C0037284  |  skin lesions
C0037284  |  skin lesion
C0037274  |  skin disease
C0037274  |  dermatosis
C0036220  |  kaposi's sarcoma
C0035435  |  rheumatic disease
C0034069  |  pulmonary fibrosis
C0034050  |  pulmonary alveolar proteinosis
C0033975  |  psychosis
C0033806  |  pseudohypoparathyroidism
C0033774  |  pruritus
C0033774  |  itching
C0032453  |  chronic atrophic polychondritis
C0031212  |  personality disorders
C0031099  |  periodontitis
C0031090  |  periodontal disease
C0030809  |  pemphigus vulgaris
C0030805  |  bullous pemphigoid
C0029400  |  osteitis
C0029166  |  oral manifestations
C0029166  |  oral manifestation
C0028242  |  nocardiosis
C0027051  |  myocardial infarction
C0027030  |  myiasis
C0026946  |  mycoses
C0025517  |  metabolism disorders
C0025517  |  metabolic disorders
C0024305  |  non-hodgkin lymphoma
C0024299  |  lymphoma
C0023895  |  hepatopathy
C0023890  |  liver cirrhosis
C0023646  |  lichen planus
C0023467  |  acute myeloid leukaemia
C0023321  |  lentigines
C0023241  |  legionella pneumonia
C0022658  |  kidney diseases
C0022602  |  solar keratosis
C0022602  |  actinic keratoses
C0022596  |  palmoplantar keratoderma
C0022593  |  keratoses
C0022572  |  keratoacanthomas
C0022572  |  keratoacanthoma
C0022408  |  joint diseases
C0022408  |  joint disease
C0022408  |  inflammatory arthropathy
C0022408  |  inflammatory arthropathies
C0022408  |  arthrosis
C0022408  |  arthropathy
C0022408  |  arthropathies
C0021053  |  immune dysfunction
C0020615  |  hypoglycemia
C0020476  |  hyperlipoproteinemias
C0020473  |  hyperlipidaemia
C0020443  |  hypercholesterolaemia
C0019655  |  histoplasmosis
C0018923  |  haemangiosarcoma
C0018799  |  heart disease
C0017677  |  geographic tongue
C0017661  |  iga nephropathy
C0017577  |  desquamative gingivitis
C0017566  |  gingival hyperplasia
C0016412  |  folate deficiency
C0015411  |  eye manifestations
C0015230  |  rash
C0014518  |  toxic epidermal necrolysis
C0014518  |  lyell's syndrome
C0014130  |  hormone imbalance
C0011633  |  dermatomyositis
C0011616  |  contact sensitivity
C0011616  |  contact dermatitis
C0011615  |  atopic dermatitis
C0011606  |  exfoliative dermatitis
C0011603  |  skin inflammation
C0011303  |  demyelinating disease
C0010823  |  cytomegalovirus infection
C0008370  |  cholestasis
C0007570  |  coeliac disease
C0007570  |  celiac disease
C0007222  |  cardiovascular diseases
C0007137  |  squamous cell carcinomas
C0007137  |  squamous cell carcinoma
C0007137  |  epidermoid carcinoma
C0007117  |  basalioma
C0007114  |  skin cancer
C0007114  |  cancer of the skin
C0006325  |  bruxism
C0005743  |  blepharoconjunctivitis
C0005716  |  blastomycosis
C0004153  |  atherosclerosis
C0003873  |  r arthritis
C0003872  |  psoriatic arthritis
C0003864  |  inflammatory arthritis
C0003864  |  arthritis
C0002888  |  megaloblastic anemia
C0002726  |  amyloidosis
C0002020  |  alexithymia
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:92)
C0003864  |  arthritis  |  72
C0003872  |  psoriatic arthritis  |  45
C0948265  |  metabolic syndrome  |  31
C0028754  |  obesity  |  29
C0003864  |  inflammatory arthritis  |  23
C0011570  |  depression  |  23
C0042373  |  vascular disease  |  18
C0007222  |  cardiovascular disease  |  17
C0041296  |  tuberculosis  |  16
C0020538  |  hypertension  |  14
C0033774  |  pruritus  |  13
C0009450  |  infection  |  13
C0019196  |  hepatitis c  |  10
C0037284  |  skin lesions  |  10
C0004153  |  atherosclerosis  |  9
C0041834  |  erythema  |  9
C0027051  |  myocardial infarction  |  7
C0037284  |  skin lesion  |  7
C0231303  |  distress  |  7
C0022408  |  arthropathy  |  7
C0025517  |  metabolic disorders  |  7
C0038454  |  stroke  |  6
C0003467  |  anxiety  |  6
C0007137  |  squamous cell carcinoma  |  5
C0011615  |  atopic dermatitis  |  5
C0030193  |  pain  |  5
C0021311  |  infections  |  5
C0038013  |  ankylosing spondylitis  |  5
C0030805  |  bullous pemphigoid  |  5
C0040261  |  onychomycosis  |  5
C0037274  |  skin disease  |  4
C0042769  |  virus infection  |  4
C0239946  |  liver fibrosis  |  4
C0031099  |  periodontitis  |  4
C0030807  |  pemphigus  |  4
C0235378  |  hepatotoxicity  |  4
C0003873  |  rheumatoid arthritis  |  4
C0038012  |  spondylitis  |  4
C0033953  |  sexual dysfunction  |  4
C0042373  |  vascular diseases  |  3
C0018799  |  heart disease  |  3
C0011603  |  skin inflammation  |  3
C0030809  |  pemphigus vulgaris  |  3
C1301700  |  cardiovascular morbidity  |  3
C0022408  |  inflammatory arthropathy  |  3
C0024299  |  lymphoma  |  3
C1867449  |  psors1  |  3
C0086132  |  depressive symptoms  |  2
C0039103  |  synovitis  |  2
C0023895  |  liver disease  |  2
C0263313  |  pemphigus foliaceus  |  2
C0020473  |  hyperlipidaemia  |  2
C0242490  |  enthesopathy  |  2
C0042373  |  vascular disorders  |  2
C0022408  |  joint disease  |  2
C0683381  |  inflammatory joint disease  |  2
C0035435  |  rheumatic disease  |  2
C0019163  |  hepatitis b  |  2
C0239946  |  hepatic fibrosis  |  2
C0007222  |  cardiovascular diseases  |  2
C0042164  |  uveitis  |  2
C0263367  |  koebner phenomenon  |  1
C0041408  |  turner's syndrome  |  1
C0154251  |  disorders of lipid metabolism  |  1
C0039128  |  syphilis  |  1
C0025202  |  melanoma  |  1
C0233401  |  psychiatric symptoms  |  1
C0020443  |  hypercholesterolaemia  |  1
C0221014  |  secondary amyloidosis  |  1
C0039494  |  temporomandibular disorders  |  1
C0011616  |  contact dermatitis  |  1
C0027030  |  myiasis  |  1
C0086873  |  scarring alopecia  |  1
C0221260  |  nail dystrophies  |  1
C0017661  |  iga nephropathy  |  1
C0017677  |  geographic tongue  |  1
C0037274  |  dermatosis  |  1
C1290884  |  inflammatory disorder  |  1
C0003862  |  joint pain  |  1
C0043037  |  warts  |  1
C0031090  |  periodontal disease  |  1
C0019655  |  histoplasmosis  |  1
C0007570  |  celiac disease  |  1
C0028242  |  nocardiosis  |  1
C0036220  |  kaposi's sarcoma  |  1
C0033774  |  itching  |  1
C0020542  |  pulmonary hypertension  |  1
C0586407  |  skin symptoms  |  1
C0002726  |  amyloidosis  |  1
C0079772  |  t-cell lymphoma  |  1
C0042170  |  vogt-koyanagi-harada syndrome  |  1
C0162820  |  allergic contact dermatitis  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:195)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1008953209531896385SDC4umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.0023670322010NA2045352086TC
rs10207602500601222806IKZF3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014NFKB14102593288CG
rs1020760250060124790NFKB1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0097158262014NFKB14102593288CG
rs1020760250060123902LAG3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014NFKB14102593288CG
rs1020760250060123593IL12Bumls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.3029906292014NFKB14102593288CG
rs102076025006012939CD27umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0005428842014NFKB14102593288CG
rs10207602500601251752ERAP1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.2461672182014NFKB14102593288CG
rs1047781255748252524FUT2umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.122014FUT2;LOC1054476451948703374AT
rs10484552NA3133HLA-Eumls:C0033860GADNA0.008338753NANA630516259GC
rs1076160191692547248TSC1umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.0026384742009TSC19132900647CT
rs107820012095318954620FBXL19umls:C0033860GWASCATGenome-wide association analysis identifies three psoriasis susceptibility loci.0.2423670322010FBXL191630931304GA
rs107820012557482554620FBXL19umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.2423670322014FBXL191630931304GA
rs107820012095318954620FBXL19umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.2423670322010FBXL191630931304GA
rs108529362500601222806IKZF3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014ZPBP21739875461CT
rs108529362500601251752ERAP1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.2461672182014ZPBP21739875461CT
rs10852936250060123593IL12Bumls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.3029906292014ZPBP21739875461CT
rs1085293625006012939CD27umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0005428842014ZPBP21739875461CT
rs10852936250060124790NFKB1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0097158262014ZPBP21739875461CT
rs10852936250060123902LAG3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014ZPBP21739875461CT
rs1120902618647855149233IL23Rumls:C0033860BeFreeThe rare allele of a non-synonymous interleukin 23 receptor (IL23R) single nucleotide polymorphism (SNP) rs11209026 (p.Arg381Gln) confers strong protection against Crohn disease (CD) and psoriasis.0.3105249882009IL23R167240275GA
rs1120902623563201149233IL23Rumls:C0033860BeFreeWe and others have shown that the minor, nonconserved allele Gln381 of the Arg381Gln single-nucleotide polymorphism (rs11209026G>A) of the IL-23 receptor gene (IL23R) protects against psoriasis.0.3105249882013IL23R167240275GA
rs112090261918998027034ACAD8umls:C0033860BeFreeAdditionally, observed stronger associations with SNPs rs11209026 and rs11465804 upon exclusion of IBD and/or psoriasis cases may represent an independent association with AS.0.0010857672009IL23R167240275GA
rs1120902621364948149233IL23Rumls:C0033860BeFreeGenome-wide association studies have shown that the IL23R R381Q gene variant protects against psoriasis, Crohn's disease and ankylosing spondylitis.0.3105249882011IL23R167240275GA
rs1120902620953190149233IL23Rumls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.3105249882010IL23R167240275GA
rs11209026183694593593IL12Bumls:C0033860BeFreeWe replicated the previously reported association with interleukin 23 receptor and interleukin 12B (IL12B) polymorphisms in PS and PSA cohorts (IL23R: rs11209026, U.S. PS, P = 1.4x10(-4); U.K. PSA: P = 8.0x10(-4); IL12B:rs6887695, U.S. PS, P = 5x10(-5) and U.K. PSA, P = 1.3x10(-3)) and detected an independent association in the IL23R region with a SNP 4 kb upstream from IL12RB2 (P = 0.001).0.3029906292008IL23R167240275GA
rs1120902624140476149233IL23Rumls:C0033860BeFreeThis study aims to assess whether the association between the non-susceptibility allelic variants of IL12B single-nucleotide polymorphism (SNPs) rs3212227 and rs6887695, IL23R SNPs rs11209026 and rs7530511, IL6 SNP rs1800795 and HLA-Cw6 could be correlated with decreased risk for psoriasis.0.3105249882013IL23R167240275GA
rs1120902618369459149233IL23Rumls:C0033860BeFreeWe replicated the previously reported association with interleukin 23 receptor and interleukin 12B (IL12B) polymorphisms in PS and PSA cohorts (IL23R: rs11209026, U.S. PS, P = 1.4x10(-4); U.K. PSA: P = 8.0x10(-4); IL12B:rs6887695, U.S. PS, P = 5x10(-5) and U.K. PSA, P = 1.3x10(-3)) and detected an independent association in the IL23R region with a SNP 4 kb upstream from IL12RB2 (P = 0.001).0.3105249882008IL23R167240275GA
rs1120903219189980149233IL23Rumls:C0033860BeFreeIn the UK case-control study with new cases, four of the eight SNPs showed significant associations, whereas in the extended UK study, seven of the eight IL-23R SNPs showed significant associations (P < 0.05) with AS, maximal with rs11209032 (P < 10(-5), OR 1.3), when cases with IBD and/or psoriasis were excluded.0.3105249882009NA167274409GA
rs114658041918998027034ACAD8umls:C0033860BeFreeAdditionally, observed stronger associations with SNPs rs11209026 and rs11465804 upon exclusion of IBD and/or psoriasis cases may represent an independent association with AS.0.0010857672009IL23R167236843TG
rs11584340181932442312FLGumls:C0033860BeFreeAssociation between P478S polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population in Taiwan.0.0069914752008FLG;FLG-AS11152313454GA
rs116520752252141979092CARD14umls:C0033860BeFreeOver 20 CARD14 polymorphisms were also genotyped, and meta-analysis revealed an association between psoriasis and rs11652075 (c.2458C>T [p.Arg820Trp]; p value = 2.1 × 10(-6)).0.1240716282012CARD14;LOC1053719201780205094CT
rs11652075225214193107HLA-Cumls:C0033860BeFreeIn the two largest psoriasis cohorts, evidence for association increased when rs11652075 was conditioned on HLA-Cw*0602 (PSORS1).0.2527491072012CARD14;LOC1053719201780205094CT
rs116520752390569979092CARD14umls:C0033860BeFreeSNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort.0.1240716282013CARD14;LOC1053719201780205094CT
rs117953432557482523586DDX58umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.2402714422014DDX58932523739TC
rs12203586NA3119HLA-DQB1umls:C0033860GADNA0.017654991NANA632711814GC
rs12505442248280457178ZMIZ1umls:C0033860GWASCATThree of the shared loci are also genome-wide significantly associated with PS alone (10q22 at ZMIZ1, p(rs1250544) = 3.53 × 10(-8), 11q13 near PRDX5, p(rs694739) = 3.71 × 10(-09), 22q11 at YDJC, p(rs181359) = 8.02 × 10(-10)).0.1202714422012ZMIZ11079273128GA
rs12505442248280457178ZMIZ1umls:C0033860BeFreeThree of the shared loci are also genome-wide significantly associated with PS alone (10q22 at ZMIZ1, p(rs1250544) = 3.53 × 10(-8), 11q13 near PRDX5, p(rs694739) = 3.71 × 10(-09), 22q11 at YDJC, p(rs181359) = 8.02 × 10(-10)).0.1202714422012ZMIZ11079273128GA
rs12586317209531899692KIAA0391umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.1223670322010KIAA03911435212966TC
rs12586317255748259692KIAA0391umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1223670322014KIAA03911435212966TC
rs12586317209531899692KIAA0391umls:C0033860GWASCATGenome-wide association analysis identifies three psoriasis susceptibility loci.0.1223670322010KIAA03911435212966TC
rs1265078NA54535CCHCR1umls:C0033860GADNA0.019445464NACCHCR1631144825GC
rs1265086NA54535CCHCR1umls:C0033860GADNA0.019445464NACCHCR1631142105GT
rs12720356209531907297TYK2umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.2431813582010TYK21910359299AC
rs12720356209531907297TYK2umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.2431813582010TYK21910359299AC
rs1300672298549354535CCHCR1umls:C0033860BeFreeAfter applying a Bonferroni correction for the number of SNPs tested, the SNP mapping to CCHCR1 (rs130067) retained statistically significant evidence for association (P = 6 × 10(-4) ; odds ratio [OR] = 1.15, 95% CI: 1.06-1.24); this has also been associated with psoriasis.0.0194454642013CCHCR1631150734TG
rs17132392389259150604IL20umls:C0033860BeFreeIn our previous study, a single-nucleotide polymorphism (SNP) of IL-20-1723CG (rs1713239) was found to be associated with psoriasis progression, especially in those induced by upper respiratory tract infection.0.0046145122013IL201206864130GC
rs177169422557482590134KCNH7umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1223670322014KCNH72162404181TC
rs177169422095319090134KCNH7umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.1223670322010KCNH72162404181TC
rs177169422095319090134KCNH7umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.1223670322010KCNH72162404181TC
rs177283381916925410318TNIP1umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.2501728332009NA5151098757GA
rs1799983258112084846NOS3umls:C0033860BeFreeAssociation of endothelial nitric oxide synthase Glu298Asp gene polymorphism in psoriasis cases with hypertension.0.0032672342015NOS37150999023TG
rs1800629242520777124TNFumls:C0033860BeFreeAssociation of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: a meta-analysis.0.1872939732012TNF631575254GA
rs180079524140476149233IL23Rumls:C0033860BeFreeThis study aims to assess whether the association between the non-susceptibility allelic variants of IL12B single-nucleotide polymorphism (SNPs) rs3212227 and rs6887695, IL23R SNPs rs11209026 and rs7530511, IL6 SNP rs1800795 and HLA-Cw6 could be correlated with decreased risk for psoriasis.0.3105249882013IL6;LOC541472722727026CG
rs1800925180755133596IL13umls:C0033860BeFreeA multitiered genetic association study of 25 215 single-nucleotide polymorphisms (SNPs) in three case-control sample sets (1446 patients and 1432 controls) identified three IL13-linked SNPs (rs1800925, rs20541 and rs848) associated with psoriasis.0.2507157172008IL13;LOC1019277615132657117CT
rs1800925195540223596IL13umls:C0033860BeFreeWe examined the association between IL13 polymorphisms, smoking, and PsA in two Ps sample sets genotyped for rs1800925, rs20541, and rs848.0.2507157172009IL13;LOC1019277615132657117CT
rs1801133241183778639AOC3umls:C0033860BeFreeMethylentetrahydrofolatereductase (rs1801133) polymorphism and psoriasis: contribution to oxidative stress, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report.0.0002714422013MTHFR111796321GA
rs1813592248280457178ZMIZ1umls:C0033860BeFreeThree of the shared loci are also genome-wide significantly associated with PS alone (10q22 at ZMIZ1, p(rs1250544) = 3.53 × 10(-8), 11q13 near PRDX5, p(rs694739) = 3.71 × 10(-09), 22q11 at YDJC, p(rs181359) = 8.02 × 10(-10)).0.1202714422012UBE2L32221574352GA
rs197597420953189339263C17orf51umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.0023670322010NA1722180454AG
rs20541180755133596IL13umls:C0033860BeFreeA multitiered genetic association study of 25 215 single-nucleotide polymorphisms (SNPs) in three case-control sample sets (1446 patients and 1432 controls) identified three IL13-linked SNPs (rs1800925, rs20541 and rs848) associated with psoriasis.0.2507157172008IL135132660272AG
rs20541191692543596IL13umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.2507157172009IL135132660272AG
rs20541222862123596IL13umls:C0033860BeFreeEvidence for an association between EBV-negative cHL and rs20541 (5q31, IL13: OR = 1.53, 95% CI = 1.32 to 1.76, P = 5.4 x 10(-9)), a variant previously linked to psoriasis and asthma, was observed; however, the evidence for replication was less clear.0.2507157172012IL135132660272AG
rs20541226949303596IL13umls:C0033860BeFreeThe minor allele T of rs20541 in IL13 is the risk allele for asthma but the protective allele for psoriasis.0.2507157172012IL135132660272AG
rs20541191692543596IL13umls:C0033860GWASCATGenome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.0.2507157172009IL135132660272AG
rs20541195540223596IL13umls:C0033860BeFreeWe examined the association between IL13 polymorphisms, smoking, and PsA in two Ps sample sets genotyped for rs1800925, rs20541, and rs848.0.2507157172009IL135132660272AG
rs2066808191692546773STAT2umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.1247340642009STAT21256344189AG
rs2066808209531906773STAT2umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.1247340642010STAT21256344189AG
rs2066808255748256773STAT2umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1247340642014STAT21256344189AG
rs2066808191692546773STAT2umls:C0033860GWASCATGenome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.0.1247340642009STAT21256344189AG
rs2066808209531906773STAT2umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.1247340642010STAT21256344189AG
rs20668081916925451561IL23Aumls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.1388589732009STAT21256344189AG
rs208241219169254134510UBLCP1umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.0023670322009NA5159290781GA
rs220184119169254149233IL23Rumls:C0033860GWASCATGenome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.0.3105249882009IL23R167228519AG
rs22332782557482510318TNIP1umls:C0033860GWASCATWe further identified previously unreported pleiotropic alleles with opposing effects on atopic dermatitis and psoriasis risk in PRKRA and ANXA6/TNIP1.0.2501728332014TNIP15151087628GC
rs22431581549695450604IL20umls:C0033860BeFreeAlthough association analysis of the IL-19 gene indicated that minor alleles of the IL-19 gene SNPs (rs2243188, rs2243169 and rs2243158) revealed protective effect to psoriasis and haplotype analysis of the IL-19 gene proved significant protective effect of the TGATA haplotype in case of late-onset disease, combined haplotype analysis of the IL-19 and -20 genes demonstrated that protective effect of the IL-19 gene is secondary to the susceptibility effect of the IL-20 gene.0.0046145122004IL191206834296CG
rs22431691549695450604IL20umls:C0033860BeFreeAlthough association analysis of the IL-19 gene indicated that minor alleles of the IL-19 gene SNPs (rs2243188, rs2243169 and rs2243158) revealed protective effect to psoriasis and haplotype analysis of the IL-19 gene proved significant protective effect of the TGATA haplotype in case of late-onset disease, combined haplotype analysis of the IL-19 and -20 genes demonstrated that protective effect of the IL-19 gene is secondary to the susceptibility effect of the IL-20 gene.0.0046145122004IL191206836189AG
rs22431881549695450604IL20umls:C0033860BeFreeAlthough association analysis of the IL-19 gene indicated that minor alleles of the IL-19 gene SNPs (rs2243188, rs2243169 and rs2243158) revealed protective effect to psoriasis and haplotype analysis of the IL-19 gene proved significant protective effect of the TGATA haplotype in case of late-onset disease, combined haplotype analysis of the IL-19 and -20 genes demonstrated that protective effect of the IL-19 gene is secondary to the susceptibility effect of the IL-20 gene.0.0046145122004IL19;LOC1053728781206841127AC
rs2303138238972744792NFKBIAumls:C0033860BeFreeWe identified the missense variant rs2303138 (p.Ala763Thr) within the LNPEP gene associated with psoriasis (Pcombined=1.83 × 10(-13), odds ratio=1.16) and validated four previously reported genes: IL28RA, NFKBIA, TRAF3IP2, and CARD14 (9.74 × 10(-11)P9.37 × 10(-5)), which confirmed the involvement of the nuclear factor-κB signaling pathway in psoriasis pathogenesis.0.1252769482013LNPEP597015006GA
rs23031382389727410758TRAF3IP2umls:C0033860BeFreeWe identified the missense variant rs2303138 (p.Ala763Thr) within the LNPEP gene associated with psoriasis (Pcombined=1.83 × 10(-13), odds ratio=1.16) and validated four previously reported genes: IL28RA, NFKBIA, TRAF3IP2, and CARD14 (9.74 × 10(-11)P9.37 × 10(-5)), which confirmed the involvement of the nuclear factor-κB signaling pathway in psoriasis pathogenesis.0.2500869572013LNPEP597015006GA
rs23031382389727479092CARD14umls:C0033860BeFreeWe identified the missense variant rs2303138 (p.Ala763Thr) within the LNPEP gene associated with psoriasis (Pcombined=1.83 × 10(-13), odds ratio=1.16) and validated four previously reported genes: IL28RA, NFKBIA, TRAF3IP2, and CARD14 (9.74 × 10(-11)P9.37 × 10(-5)), which confirmed the involvement of the nuclear factor-κB signaling pathway in psoriasis pathogenesis.0.1240716282013LNPEP597015006GA
rs230313823897274163702IFNLR1umls:C0033860BeFreeWe identified the missense variant rs2303138 (p.Ala763Thr) within the LNPEP gene associated with psoriasis (Pcombined=1.83 × 10(-13), odds ratio=1.16) and validated four previously reported genes: IL28RA, NFKBIA, TRAF3IP2, and CARD14 (9.74 × 10(-11)P9.37 × 10(-5)), which confirmed the involvement of the nuclear factor-κB signaling pathway in psoriasis pathogenesis.0.1229099162013LNPEP597015006GA
rs23950291836945910866HCP5umls:C0033860BeFreeHowever, rs2395029 encoding the G2V polymorphism within the class I gene HCP5 (combined P = 2.13x10(-26) in U.S. cases) yielded the highest ORs with both PS and PSA (4.1 and 3.2 respectively).0.1205428842008HCP5631464003TG
rs23950291836945910866HCP5umls:C0033860GWASCATHowever, rs2395029 encoding the G2V polymorphism within the class I gene HCP5 (combined P = 2.13x10(-26) in U.S. cases) yielded the highest ORs with both PS and PSA (4.1 and 3.2 respectively).0.1205428842008HCP5631464003TG
rs240993209531905980REV3Lumls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.1223670322010REV3L6111352511TC
rs240993209531905980REV3Lumls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.1223670322010REV3L6111352511TC
rs24766012254457326191PTPN22umls:C0033860BeFreePTPN22 C1858T and the risk of psoriasis: a meta-analysis.0.0118114162012PTPN22;AP4B1-AS11113834946AG
rs254689020953188285626LOC285626umls:C0033860GWASCATGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.0.122010LOC2856265159332892AG
rs2647087NA3119HLA-DQB1umls:C0033860GADNA0.017654991NANA632713272AC
rs2700987255748259844ELMO1umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.122014ELMO1737346633CA
rs2752425574825831CASTumls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1223670322014CAST;ERAP1596766240AG
rs275242095319051752ERAP1umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.2461672182010CAST;ERAP1596766240AG
rs275242557482551752ERAP1umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.2461672182014CAST;ERAP1596766240AG
rs2752420953190831CASTumls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.1223670322010CAST;ERAP1596766240AG
rs275242095319051752ERAP1umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.2461672182010CAST;ERAP1596766240AG
rs275242228621251752ERAP1umls:C0033860BeFreeNotably, one additional psoriasis-associated variant, rs27524 (5q15, ERAP1), showed evidence of an association with cHL in the genome-wide association study (OR = 1.21, 95% CI = 1.10 to 1.33, P = 1.5 × 10(-4)) and replication series (P = .03).0.2461672182012CAST;ERAP1596766240AG
rs2752420953190831CASTumls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.1223670322010CAST;ERAP1596766240AG
rs280519209531907297TYK2umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.2431813582010TYK21910362257AG
rs280519209531907297TYK2umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.2431813582010TYK21910362257AG
rs2818752142252141879092CARD14umls:C0033860BeFreeCARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-type CARD14, the p.Gly117Ser and p.Glu138Ala substitutions were shown to lead to enhanced NF-kB activation and upregulation of a subset of psoriasis-associated genes in keratinocytes.0.1240716282012CARD141780183976AC
rs2818752152252141879092CARD14umls:C0033860BeFreeCARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-type CARD14, the p.Gly117Ser and p.Glu138Ala substitutions were shown to lead to enhanced NF-kB activation and upregulation of a subset of psoriasis-associated genes in keratinocytes.0.1240716282012CARD141780182790GA
rs2856726NA3119HLA-DQB1umls:C0033860GADNA0.017654991NANA632698944AT
rs2858333NA3119HLA-DQB1umls:C0033860GADNA0.017654991NANA632713308AG
rs2858881221255903118HLA-DQA2umls:C0033860BeFreeWith four regression models obtained, two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that multiple loci outside PSOR1 locus were associated with psoriasis.0.0010857672011NA632736068TC
rs2858881221255906278S100A7umls:C0033860BeFreeWith four regression models obtained, two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that multiple loci outside PSOR1 locus were associated with psoriasis.0.1232573022011NA632736068TC
rs2910164252097591956EGFRumls:C0033860BeFreeThese findings indicate that the rs2910164G allele in miR-146a weakens its suppression on the proliferation of keratinocytes probably through the decreased inhibition of the target gene, EGFR, which may account for the increased risk of psoriasis in this study population.0.0008143262014LOC285628;MIR146A5160485411CG
rs3093024258795579034CCRL2umls:C0033860BeFreeEvaluation of blood redox-balance, nitric oxide content and CCR6 rs3093024 in the genetic susceptibility during psoriasis.0.0046145122016CCR6;LOC1053781226167119305AG
rs3094187NA54535CCHCR1umls:C0033860GADNA0.019445464NATCF19;CCHCR1631159167CT
rs3094205NA170679PSORS1C1umls:C0033860GADNA0.008815624NAPSORS1C1631124085AG
rs3130453NA54535CCHCR1umls:C0033860GADNA0.019445464NATCF19;CCHCR1631157072CT
rs3130573NA170679PSORS1C1umls:C0033860GADNA0.008815624NAPSORS1C1;PSORS1C2631138491AG
rs3130573NA170680PSORS1C2umls:C0033860GADNA0.008358616NAPSORS1C1;PSORS1C2631138491AG
rs321222724140476149233IL23Rumls:C0033860BeFreeThis study aims to assess whether the association between the non-susceptibility allelic variants of IL12B single-nucleotide polymorphism (SNPs) rs3212227 and rs6887695, IL23R SNPs rs11209026 and rs7530511, IL6 SNP rs1800795 and HLA-Cw6 could be correlated with decreased risk for psoriasis.0.3105249882013IL12B5159315942TG
rs3212227232970153593IL12Bumls:C0033860BeFreeMeta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis.0.3029906292012IL12B5159315942TG
rs3213094191692553593IL12Bumls:C0033860GWASCATPsoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.0.3029906292009IL12B5159323761CT
rs3213094209531903593IL12Bumls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.3029906292010IL12B5159323761CT
rs3213094209531903593IL12Bumls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.3029906292010IL12B5159323761CT
rs339805002320227153342IL17Dumls:C0033860BeFreeIn the absence of IL-17 signaling, IL-22 was the main contributor to skin inflammation, which provides a molecular mechanism for the association of Act1(D10N) with psoriasis susceptibility.0.0054288372013TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002502437710758TRAF3IP2umls:C0033860BeFreeA missense single nucleotide polymorphism (rs33980500; SNP-D10N) that resulted in the substitution of an asparagine for an aspartic acid at position 10 of ACT1 (ACT1-D10N) is associated with psoriasis susceptibility.0.2500869572014TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002095318810758TRAF3IP2umls:C0033860GAD[Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.]0.2500869572010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs3398050020953188643749TRAF3IP2-AS1umls:C0033860GWASCATGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.0.122010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs33980500232022713320HSP90AA1umls:C0033860BeFreeThe D10N variant of Act1 (Act1(D10N)) that is linked to susceptibility to psoriasis was defective in its interaction with hsp90, which resulted in a global loss of Act1 function.0.0005428842013TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002320227110758TRAF3IP2umls:C0033860BeFreeThe psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90.0.2500869572013TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002320227150616IL22umls:C0033860BeFreeIn the absence of IL-17 signaling, IL-22 was the main contributor to skin inflammation, which provides a molecular mechanism for the association of Act1(D10N) with psoriasis susceptibility.0.0073289312013TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002095318810758TRAF3IP2umls:C0033860GWASCATGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.0.2500869572010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs361525242520777124TNFumls:C0033860BeFreeAssociation of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: a meta-analysis.0.1872939732012TNF631575324GA
rs38033691836945957511COG6umls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0029099162008TNFAIP8L3;PIRC661551083632TC
rs38033691836945910186LHFPumls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0002714422008TNFAIP8L3;PIRC661551083632TC
rs3823418NA170679PSORS1C1umls:C0033860GADNA0.008815624NAPSORS1C1631133165GA
rs408561319169255353142LCE3Aumls:C0033860GAD[Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.]0.0023670322009NA1152577542TG
rs408561319169255353145LCE3Eumls:C0033860GAD[Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.]0.0047340642009NA1152577542TG
rs40856131916925584648LCE3Dumls:C0033860GAD[Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.]0.1226384742009NA1152577542TG
rs411278820953190353145LCE3Eumls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.0047340642010NA1152578800AG
rs443198NA4855NOTCH4umls:C0033860GADNA0.002638474NANOTCH4632222629AG
rs458017209531905980REV3Lumls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.1223670322010REV3L6111374888TC
rs464920320953190163702IFNLR1umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.1229099162010NA124193430GA
rs465969255748255980REV3Lumls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1223670322014REV3L;LOC1053779436111334327GA
rs4780355224828048651SOCS1umls:C0033860GWASCATWe identified seven susceptibility loci outside the human leukocyte antigen region (9p24 near JAK2, 10q22 at ZMIZ1, 11q13 near PRDX5, 16p13 near SOCS1, 17q21 at STAT3, 19p13 near FUT2, and 22q11 at YDJC) shared between PS and CD with genome-wide significance (p < 5 × 10(-8)) and confirmed four already established PS and CD risk loci (IL23R, IL12B, REL, and TYK2).0.1202714422012SOCS1;LOC1053710821611254001TC
rs4795067209531894843NOS2umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.2434527992010NOS21727779649AG
rs4795067209531894843NOS2umls:C0033860GWASCATGenome-wide association analysis identifies three psoriasis susceptibility loci.0.2434527992010NOS21727779649AG
rs4795067259232164843NOS2umls:C0033860BeFreeAdditionally, we found genome-wide significant association to the previously reported psoriasis risk loci; NOS2 (rs4795067, p=5.27×10(-9)).0.2434527992015NOS21727779649AG
rs495337255748259825SPATA2umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.1250055062014SPATA22049905793GA
rs495337183643909825SPATA2umls:C0033860GAD[Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.]0.1250055062008SPATA22049905793GA
rs495337209531899825SPATA2umls:C0033860GWASCATGenome-wide association analysis identifies three psoriasis susceptibility loci.0.1250055062010SPATA22049905793GA
rs495337183643909825SPATA2umls:C0033860GWASCATIdentification of ZNF313/RNF114 as a novel psoriasis susceptibility gene.0.1250055062008SPATA22049905793GA
rs495337209531899825SPATA2umls:C0033860GAD[Genome-wide association analysis identifies three psoriasis susceptibility loci.]0.1250055062010SPATA22049905793GA
rs582757255748257128TNFAIP3umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.2525398652014TNFAIP36137876687CT
rs610604209531907128TNFAIP3umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.2525398652010TNFAIP36137878280GT
rs610604191692547128TNFAIP3umls:C0033860GAD[Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.]0.2525398652009TNFAIP36137878280GT
rs61060423521149353143LCE3Bumls:C0033860BeFreeThe aim of our study was to analyse the presence of three different psoriasis susceptibility genetic variations (HLA-Cw6; TNFAIP3 rs610604 polymorphism; LCE3B/3C gene deletions) in a cohort of patients affected by moderate to severe psoriasis under ustekinumab treatment.0.1408026732013TNFAIP36137878280GT
rs610604235211497128TNFAIP3umls:C0033860BeFreeThe aim of our study was to analyse the presence of three different psoriasis susceptibility genetic variations (HLA-Cw6; TNFAIP3 rs610604 polymorphism; LCE3B/3C gene deletions) in a cohort of patients affected by moderate to severe psoriasis under ustekinumab treatment.0.2525398652013TNFAIP36137878280GT
rs610604191692547128TNFAIP3umls:C0033860GWASCATGenome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.0.2525398652009TNFAIP36137878280GT
rs610604209531907128TNFAIP3umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.2525398652010TNFAIP36137878280GT
rs61816761215643282312FLGumls:C0033860BeFreeThe filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results from general population study and meta-analysis.0.0069914752012FLG;FLG-AS11152313385GA,T
rs6311201985763356HTR2Aumls:C0033860BeFreeWe investigated a possible association between the -1438A/G single nucleotide polymorphism (rs6311) in the promoter region of 5-HTR2A gene and psoriasis in a Thai population.0.0029099162010HTR2A1346897343CT
rs67012161836945910186LHFPumls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0002714422008LCE1C1152806050CT
rs67012161836945957511COG6umls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0029099162008LCE1C1152806050CT
rs67384697225773633813KIR3DS1umls:C0033860BeFreeThis includes several HLA class I alleles associated with HIV-1 control; amino acid residues at HLA-B positions 67, 70, and 97 that mediate HIV-1 peptide binding; and the deletion polymorphism rs67384697 associated with high surface expression of HLA-C. We also found that the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased psoriasis susceptibility.0.0050055062012HLA-C631268906C-
rs67384697225773633106HLA-Bumls:C0033860BeFreeThis includes several HLA class I alleles associated with HIV-1 control; amino acid residues at HLA-B positions 67, 70, and 97 that mediate HIV-1 peptide binding; and the deletion polymorphism rs67384697 associated with high surface expression of HLA-C. We also found that the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased psoriasis susceptibility.0.0544840052012HLA-C631268906C-
rs67384697225773633107HLA-Cumls:C0033860BeFreeThis includes several HLA class I alleles associated with HIV-1 control; amino acid residues at HLA-B positions 67, 70, and 97 that mediate HIV-1 peptide binding; and the deletion polymorphism rs67384697 associated with high surface expression of HLA-C. We also found that the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased psoriasis susceptibility.0.2527491072012HLA-C631268906C-
rs6809854209531906304SATB1umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.0023670322010NA318742931AG
rs6887695232970153593IL12Bumls:C0033860BeFreeMeta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis.0.3029906292012NA5159395637GC
rs688769518369459149233IL23Rumls:C0033860BeFreeWe replicated the previously reported association with interleukin 23 receptor and interleukin 12B (IL12B) polymorphisms in PS and PSA cohorts (IL23R: rs11209026, U.S. PS, P = 1.4x10(-4); U.K. PSA: P = 8.0x10(-4); IL12B:rs6887695, U.S. PS, P = 5x10(-5) and U.K. PSA, P = 1.3x10(-3)) and detected an independent association in the IL23R region with a SNP 4 kb upstream from IL12RB2 (P = 0.001).0.3105249882008NA5159395637GC
rs688769524140476149233IL23Rumls:C0033860BeFreeThis study aims to assess whether the association between the non-susceptibility allelic variants of IL12B single-nucleotide polymorphism (SNPs) rs3212227 and rs6887695, IL23R SNPs rs11209026 and rs7530511, IL6 SNP rs1800795 and HLA-Cw6 could be correlated with decreased risk for psoriasis.0.3105249882013NA5159395637GC
rs6887695183694593593IL12Bumls:C0033860BeFreeWe replicated the previously reported association with interleukin 23 receptor and interleukin 12B (IL12B) polymorphisms in PS and PSA cohorts (IL23R: rs11209026, U.S. PS, P = 1.4x10(-4); U.K. PSA: P = 8.0x10(-4); IL12B:rs6887695, U.S. PS, P = 5x10(-5) and U.K. PSA, P = 1.3x10(-3)) and detected an independent association in the IL23R region with a SNP 4 kb upstream from IL12RB2 (P = 0.001).0.3029906292008NA5159395637GC
rs6906662NA10665C6orf10umls:C0033860GADNA0.004734064NAC6orf10;LOC101929163632298729GA
rs6916062NA4855NOTCH4umls:C0033860GADNA0.002638474NANA632251264CT
rs6947392248280457178ZMIZ1umls:C0033860BeFreeThree of the shared loci are also genome-wide significantly associated with PS alone (10q22 at ZMIZ1, p(rs1250544) = 3.53 × 10(-8), 11q13 near PRDX5, p(rs694739) = 3.71 × 10(-09), 22q11 at YDJC, p(rs181359) = 8.02 × 10(-10)).0.1202714422012LOC1027238781164329761AG
rs70287325574825400957LINC01185umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.122014LINC01185260854407CT
rs70287320953190400957LINC01185umls:C0033860GWASCATA genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.0.122010LINC01185260854407CT
rs7342321565496179092CARD14umls:C0033860BeFreeA DNA variant, rs734232, altering a RUNX1 binding site was recently reported as susceptibility allele at PSORS2 (17q25) in cohorts of psoriasis patients from the US.0.1240716282005SLC9A3R11774769592GA
rs753051124140476149233IL23Rumls:C0033860BeFreeThis study aims to assess whether the association between the non-susceptibility allelic variants of IL12B single-nucleotide polymorphism (SNPs) rs3212227 and rs6887695, IL23R SNPs rs11209026 and rs7530511, IL6 SNP rs1800795 and HLA-Cw6 could be correlated with decreased risk for psoriasis.0.3105249882013IL23R167219704TC
rs7574865200397856775STAT4umls:C0033860BeFreeWe recently reported for the first time as a PS-associated SNP the signal transducer and activator of transcription-4 (STAT4) rs7574865 polymorphism, which is also associated with several autoimmune diseases.0.0029099162010STAT42191099907TG
rs758739250060123593IL12Bumls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.3029906292014NCAPD2126517203GC
rs75873925006012939CD27umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0005428842014NCAPD2126517203GC
rs758739250060124790NFKB1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0097158262014NCAPD2126517203GC
rs7587392500601251752ERAP1umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.2461672182014NCAPD2126517203GC
rs758739250060123902LAG3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014NCAPD2126517203GC
rs7587392500601222806IKZF3umls:C0033860BeFreeWe confirmed four known psoriasis susceptibility loci (IL12B, IFIH1, ERAP1 and RNF114; 2.30 × 10(-20)≤P≤2.41 × 10(-7)) and identified three new susceptibility loci: 4q24 (NFKB1) at rs1020760 (P=2.19 × 10(-8)), 12p13.3 (CD27-LAG3) at rs758739 (P=4.08 × 10(-8)) and 17q12 (IKZF3) at rs10852936 (P=1.96 × 10(-8)).0.0002714422014NCAPD2126517203GC
rs77875845182566919625AATKumls:C0033860BeFreeTo identify the mutations responsible for the psoriasis in this family, we sequenced 78 genes within the region and found four gene variants, p.Ala201Val in CD7, c.-625A>C in zinc-finger protein 750 (ZNF750), p.Asp189Asn in C17orf56, and p.Ala568Thr in AATK cosegregated with the disease.0.0002714422008ENTHD2;LOC1053719251781231983CT
rs7787584518256691146705ENTHD2umls:C0033860BeFreeTo identify the mutations responsible for the psoriasis in this family, we sequenced 78 genes within the region and found four gene variants, p.Ala201Val in CD7, c.-625A>C in zinc-finger protein 750 (ZNF750), p.Asp189Asn in C17orf56, and p.Ala568Thr in AATK cosegregated with the disease.0.0002714422008ENTHD2;LOC1053719251781231983CT
rs79932141836945910186LHFPumls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0002714422008COG61339776775TC
rs79932141836945957511COG6umls:C0033860BeFreeNovel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).0.0029099162008COG61339776775TC
rs79932141836945957511COG6umls:C0033860GAD[Novel associations replicated in the U.S. PS cohort included the region harboring lipoma HMGIC fusion partner (LHFP) and conserved oligomeric golgi complex component 6 (COG6) genes on chromosome 13q13 (combined P = 2x10(-6) for rs7993214; OR = 0.71), the late cornified envelope gene cluster (LCE) from the Epidermal Differentiation Complex (PSORS4) (combined P = 6.2x10(-5) for rs6701216; OR 1.45) and a region of LD at 15q21 (combined P = 2.9x10(-5) for rs3803369; OR = 1.43).]0.0029099162008COG61339776775TC
rs8016947209531905687PSMA6umls:C0033860GAD[A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.]0.0047340642010NA1435363460TG
rs8192583NA4855NOTCH4umls:C0033860GADNA0.002638474NANOTCH4;GPSM3632195497GA
rs8192591NA4855NOTCH4umls:C0033860GADNA0.002638474NANOTCH4632218019CT
rs825921655935574449MIR492umls:C0033860BeFreeOur study suggests that miR-492 may physiologically suppress BSG expression and the BSG rs8259 polymorphism is associated with decreased psoriasis susceptibility through affecting miR-492 binding.0.0002714422011BSG19582927TA
rs8365NA177AGERumls:C0033860GADNA0.005091382NAAGER;RNF5632180626GC
rs848195540223596IL13umls:C0033860BeFreeWe examined the association between IL13 polymorphisms, smoking, and PsA in two Ps sample sets genotyped for rs1800925, rs20541, and rs848.0.2507157172009IL135132660808AC
rs848180755133596IL13umls:C0033860BeFreeA multitiered genetic association study of 25 215 single-nucleotide polymorphisms (SNPs) in three case-control sample sets (1446 patients and 1432 controls) identified three IL13-linked SNPs (rs1800925, rs20541 and rs848) associated with psoriasis.0.2507157172008IL135132660808AC
rs8920852557482581890QTRT1umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.122014QTRT11910707416GA
rs9468925221255903107HLA-Cumls:C0033860BeFreeMore importantly we find that rs9468925 in HLA-C/HLA-B is associated with both psoriasis and vitiligo, providing first important evidence that two major skin diseases share a common genetic locus in the MHC, and a basis for elucidating the molecular mechanism of skin disorders.0.2527491072011NA631291060GA
rs9468925221255903118HLA-DQA2umls:C0033860BeFreeWith four regression models obtained, two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that multiple loci outside PSOR1 locus were associated with psoriasis.0.0010857672011NA631291060GA
rs9468925221255906278S100A7umls:C0033860BeFreeWith four regression models obtained, two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that multiple loci outside PSOR1 locus were associated with psoriasis.0.1232573022011NA631291060GA
rs9468925221255903106HLA-Bumls:C0033860BeFreeMore importantly we find that rs9468925 in HLA-C/HLA-B is associated with both psoriasis and vitiligo, providing first important evidence that two major skin diseases share a common genetic locus in the MHC, and a basis for elucidating the molecular mechanism of skin disorders.0.0544840052011NA631291060GA
rs95043612557482555770EXOC2umls:C0033860GWASCATGenome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.0.122014EXOC26577820AG
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:476)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
18268095rs11121129GArs11121129231435940.000000017NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
115471992rs761301TGrs761301191692559.70E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesA
117037560rs12563353AGrs12563353209531903.00E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
124518643rs7552167AGrs7552167231435948.50E-12NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
124519920rs4649203GArs4649203209531907.00E-08NA1.13[1.05-1.22] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs4649203-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
125293084rs7536201TCrs7536201231435942.30E-12NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
162114181rs6681890GArs6681890209531903.94E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
167597119rs3762318GArs3762318209531874.19E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
167694202rs2201841AGrs2201841191692543.00E-08NA1.13NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs2201841-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
167694202rs2201841AGrs2201841209531873.00E-08PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
167702526rs11465804TGrs11465804175870579.00E-04PsoriasisNANA318 European ancestry cases; 288 European ancestry controlsEuropean(606)ALL(606)EUR(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
167705958rs11209026GArs11209026175870571.40E-04PsoriasisNANA318 European ancestry cases; 288 European ancestry controlsEuropean(606)ALL(606)EUR(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
167705958rs11209026GArs11209026209531907.00E-07NA1.49[1.27-1.74] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
167726104rs9988642TCrs9988642231435941.10E-26NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
168703843rs2772294GArs2772294183643901.91E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
171394683rs578096TCrs578096209531875.04E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
171415135rs651265AGrs651265209531876.18E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
185971357rs2066357GArs2066357209531893.00E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1152542229rs7516108TCrs7516108191692552.30E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1152550018rs4085613TGrs4085613191692557.00E-30NA1.32[1.25-1.39]1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs4085613-AResearch Support, Non-U.S. Gov'tValidation StudiesA
1152551276rs4112788AGrs4112788191692556.30E-09NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1152551276rs4112788AGrs4112788209531903.00E-10NA1.29[1.19-1.40]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1152590187rs6677595CTrs6677595231435942.10E-33NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1152591142rs1886734ACrs1886734191692551.70E-08NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesT
1152592184rs4845454CTrs4845454191692559.80E-09NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1160800559rs3766377AGrs3766377209531892.50E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1165436058rs2859731TGrs2859731183643903.72E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1187574028rs1416478GArs1416478183643903.92E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1201312033rs12126907AGrs12126907209531873.81E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1204609194rs4951087AGrs4951087183643901.25E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1225647649rs947034GArs947034209531905.87E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1237278525rs2485558GCrs2485558209531881.53E-05NANANA472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
252035257rs1541980AGrs1541980209531909.00E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
252042513rs7603003AGrs7603003209531903.49E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
261081542rs702873CTrs702873209531904.00E-09NA1.12[1.04-1.20] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs702873-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
261083506rs62149416TCrs62149416231435941.80E-17NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
261091950rs842636GArs842636209531896.00E-06NA1.15NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs842636-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
262551472rs10865331AGrs10865331231435944.70E-10NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
286826508rs11127047CTrs11127047183643903.14E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2102618370rs4851526AGrs4851526209531895.20E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2106287156rs7563743ACrs7563743209531901.52E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2113892141rs397211TCrs397211209531874.00E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
2124835210rs17010827CTrs17010827191692559.30E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesT
2125004689rs779985TCrs779985183643903.87E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2133159427rs2315377CTrs2315377209531878.68E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
2141713645rs2052910ACrs2052910183643907.10E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
2163260691rs17716942TCrs17716942209531901.00E-13NA1.29[1.17-1.43]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs17716942-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2163260691rs17716942TCrs17716942231435943.30E-18NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2198130354rs2697276AGrs2697276209531903.74E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2198135412rs2712867TCrs2712867209531904.08E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
2205022291rs7580465TCrs7580465183643906.28E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2213113079rs10497966CArs10497966183643909.90E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
34879350rs6768569AGrs6768569209531904.51E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
318784423rs6809854AGrs6809854209531901.00E-07NA1.14[1.04-1.26] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs6809854-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
326809950rs1160339GArs1160339191692551.60E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesT
348661985rs13063312GArs13063312209531904.95E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
348669447rs13324142CTrs13324142209531905.45E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
3100949842rs348867GArs348867183643909.25E-06NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
3101705809rs771785GArs771785209531905.73E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA,G
3119099049rs9837853AGrs9837853183643901.28E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
3123463708rs11718105CTrs11718105183643901.66E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
3186613364rs11716002AGrs11716002183643905.89E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
4843508rs1134921CTrs1134921183643907.78E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
415063545rs2702572CTrs2702572209531908.38E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
420160977rs12512602AGrs12512602209531893.40E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
459817797rs7667163TCrs7667163209531904.65E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
466682320rs13119904AGrs13119904209531907.59E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
471104217rs777794AGrs777794209531871.79E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
471108903rs777799GArs777799209531872.01E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
4107827275rs12186280GArs12186280209531907.78E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
4110612537rs3181191GArs3181191183643905.89E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
4118560655rs2635205AGrs2635205209531901.98E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
4136200409rs10461223CArs10461223209531891.10E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
4139847208rs4546191GArs4546191209531903.35E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
4141351711rs6837799CTrs6837799191692553.00E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
4141357957rs6536958GArs6536958191692556.90E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
4154450096rs6535921TA,C,Grs6535921183643901.90E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
4163461192rs2100763TCrs2100763209531874.69E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5614963rs1697952GArs1697952209531908.57E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
52857542rs963872GArs963872209531905.07E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
511347020rs6881516AGrs6881516191692554.60E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesA
512616305rs4702885TCrs4702885183643908.15E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
555418136rs12659696TCrs12659696209531901.09E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
564455558rs1549249TCrs1549249209531904.23E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
564484802rs1862571AGrs1862571209531906.76E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
595464398rs13164421GArs13164421209531875.21E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
596101944rs27524AGrs27524209531903.00E-11NA1.13[1.05-1.22]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs27524-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
596119273rs27432AGrs27432231435941.90E-20NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
596159992rs151823ACrs151823209531871.00E-09Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
596159992rs151823ACrs151823209531879.32E-09PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
596229272rs4869315GArs4869315209531877.82E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5131995964rs20541AGrs20541191692545.00E-15NA1.27NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs20541-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
5131995964rs20541AGrs20541209531875.00E-15PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5131996445rs1295685AGrs1295685231435943.40E-10NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
5150467189rs2233278GCrs2233278231435942.20E-42NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
5150469426rs3762999CTrs3762999209531871.16E-21PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150469426rs3762999CTrs3762999209531874.60E-19Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150469426rs3762999CTrs3762999209531875.20E-07Psoriasis (Type 2)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150473674rs999556AGrs999556209531871.90E-05Psoriasis (Type 2)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150473674rs999556AGrs999556209531874.50E-20Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150473674rs999556AGrs999556209531878.89E-22PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5150478318rs17728338GArs17728338191692541.00E-20NA1.59NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs17728338-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
5150478318rs17728338GArs17728338209531871.00E-20PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5158717789rs2082412GArs2082412191692542.00E-28NA1.44NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs2082412-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
5158750769rs3213094CTrs3213094191692553.00E-26NA1.28[1.23-1.35]1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs3213094-AResearch Support, Non-U.S. Gov'tValidation StudiesG
5158750769rs3213094CTrs3213094209531905.00E-11NA1.39[1.26-1.53]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
5158759900rs2546890AGrs2546890209531881.00E-20NA1.54[1.32-1.79]472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs2546890-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
5158764177rs7709212TCrs7709212175870577.00E-04PsoriasisNANA318 European ancestry cases; 288 European ancestry controlsEuropean(606)ALL(606)EUR(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
5158764177rs7709212TCrs7709212191692552.00E-06NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesT
5158772582rs953861GArs953861209531886.21E-18NANANA472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
5158814533rs10045431ACrs10045431175870571.00E-04PsoriasisNANA318 European ancestry cases; 288 European ancestry controlsEuropean(606)ALL(606)EUR(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
5158819615rs6861600CGrs6861600212149222.32E-08Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANACNA
5158822645rs6887695GCrs6887695212149223.96E-08Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAGNA
5158829527rs12188300ATrs12188300231435943.20E-53NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
5159879978rs2431697TCrs2431697209531871.11E-08PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5159879978rs2431697TCrs2431697209531871.30E-08Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
5162680419rs6893843TCrs6893843209531909.44E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
5173970989rs11134853TGrs11134853209531906.99E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG,T
5173975601rs6556142GArs6556142209531908.09E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
5173978707rs11134855CArs11134855209531903.97E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6549390rs2476847CTrs2476847209531907.76E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
6577820rs9504361AGrs9504361209531903.22E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6577820rs9504361AGrs9504361231435942.10E-11NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
623237776rs7740800ACrs7740800183643903.38E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
624123314rs10946673TGrs10946673183643905.92E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
630086340rs1015465TCrs1015465pha0028553.69E-15phs0000191.8NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
630103923rs2021723GArs2021723pha0028558.69E-15phs0000191.81NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACTRIM40nearGene-5NM_138700
630137866rs2107195AGrs2107195pha0028551.68E-17phs0000191.89NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATTRIM15intronNM_033229
630410988rs17476793GCrs17476793pha0028551.26E-17phs0000192.2NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
630484036rs10484552GCrs10484552pha0028557.49E-19phs0000192.32NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
630736151rs12526186CTrs12526186pha0028551.27E-12phs0000191.63NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
630756744rs4711229GTrs4711229pha0028555.43E-14phs0000191.54NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
630758466rs3131043AGrs3131043pha0028551.81E-11phs0000191.44NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
630769772rs9295917CGrs9295917pha0028555.09E-13phs0000191.65NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
630770732rs13198118TGrs13198118pha0028552.07E-12phs0000191.64NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
630782361rs9295924GArs9295924pha0028552.69E-12phs0000191.61NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
630785273rs4713380TCrs4713380pha0028556.51E-13phs0000191.64NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
630797991rs7749924CTrs7749924pha0028552.25E-12phs0000191.75NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
630848253rs7756521TCrs7756521pha0028557.58E-19phs0000191.78NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
630865725rs2239518CTrs2239518pha0028553.45E-12phs0000191.64NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACDDR1intronNM_013993
630867958rs9468843TCrs9468843pha0028559.01E-14phs0000191.68NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATDDR1nearGene-3NM_001954
630920957rs2240803GArs2240803pha0028558.19E-13phs0000191.63NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACDPCR1UTR-3NM_080870
630953105rs9295938GArs9295938pha0028559.16E-18phs0000191.85NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGMUC21intronNM_001010909
630978717rs13191258CTrs13191258pha0028553.95E-33phs0000193.11NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACMUC22intronNM_001198815
630979793rs9366764GArs9366764pha0028558.10E-18phs0000191.87NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGMUC22intronNM_001198815
630983683rs3871466TCrs3871466pha0028557.90E-17phs0000191.84NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAAMUC22intronNM_001198815
630986015rs9262492AGrs9262492pha0028552.99E-11phs0000191.45NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGMUC22intronNM_001198815
630986038rs2894176GCrs2894176pha0028559.71E-12phs0000191.45NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACMUC22intronNM_001198815
630991643rs9394031TCrs9394031pha0028558.25E-18phs0000191.88NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATMUC22intronNM_001198815
631007590rs2517552CTrs2517552pha0028558.16E-12phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631014116rs2523870CTrs2523870pha0028552.73E-12phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
631015182rs2844645GArs2844645pha0028557.29E-19phs0000191.61NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631021547rs2517527AGrs2517527pha0028551.83E-11phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATHCG22nearGene-5NR_003948
631054511rs3130955CArs3130955pha0028551.31E-20phs0000191.68NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631091862rs3094205AGrs3094205pha0028551.73E-15phs0000191.56NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATPSORS1C1intronNM_014068
631091862rs560839399AGrs3094205pha0028551.73E-15phs0000191.56NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATPSORS1C1intronNM_014068
631100942rs3823418GArs3823418212149221.11E-16Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAGPSORS1C1
631100942rs3823418GArs3823418pha0028551.17E-33phs0000192.28NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGPSORS1C1intronNM_014068
631100942rs527476195GArs3823418212149221.11E-16Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAGPSORS1C1
631100942rs527476195GArs3823418pha0028551.17E-33phs0000192.28NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGPSORS1C1intronNM_014068
631106268rs3130573AGrs3130573pha0028556.21E-15phs0000191.55NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAAPSORS1C1intronNM_014068
631109882rs1265086GTrs1265086pha0028552.69E-11phs0000191.06NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAA,CNANANA
631109882rs386525443GTrs1265086pha0028552.69E-11phs0000191.06NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAA,CNANANA
631112602rs1265078GCrs1265078212149223.44E-12Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANACCCHCR1
631112602rs1265078GCrs1265078pha0028552.04E-21phs0000191.71NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACCCHCR1intronNM_019052
631124849rs3130453CTrs3130453pha0028552.06E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACCCHCR1STOP-GAINNM_001105563
631126944rs3094187CTrs3094187pha0028553.73E-13phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGTCF19UTR-5NM_001077511
631186245rs9263967AGrs9263967pha0028557.30E-15phs0000191.53NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631187075rs3130467CTrs3130467212149221.11E-16Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANACNA
631187075rs3130467CTrs3130467pha0028551.34E-27phs0000191.88NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631190303rs3130517TCrs3130517212149224.33E-15Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANATNA
631190303rs3130517TCrs3130517pha0028551.43E-28phs0000191.91NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631205617rs3130713GTrs3130713212149225.55E-16Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAGNA
631205617rs3130713GTrs3130713pha0028559.81E-28phs0000191.91NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631206206rs3130685CTrs3130685pha0028558.58E-14phs0000191.51NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631206979rs2394895TCrs2394895212149221.13E-14Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANATNA
631206979rs2394895TCrs2394895pha0028552.59E-29phs0000191.96NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631208340rs3095250CTrs3095250pha0028552.89E-12phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
631208610rs3132496GTrs3132496pha0028552.90E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631218327rs3130425TCrs3130425pha0028551.81E-12phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631229462rs2844627CTrs2844627pha0028552.31E-36phs0000192.09NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631236175rs2853950CTrs2853950pha0028551.76E-14phs0000191.52NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGHLA-CnearGene-3XM_003403569
631240692rs2395471GArs2395471pha0028558.84E-18phs0000191.6NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAAHLA-CnearGene-5XM_003403570
631240712rs2249741AC,G,Trs2249741pha0028553.34E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANAHLA-CnearGene-5XM_003403570
631240721rs2249742CTrs2249742pha0028556.35E-18phs0000191.62NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATHLA-CnearGene-5XM_003403569
631240959rs7773175CGrs7773175pha0028554.77E-30phs0000191.92NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGHLA-CnearGene-5XM_003403570
631241761rs2524082ATrs2524082pha0028552.22E-11phs0000191.45NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATHLA-CnearGene-5XM_003403566
631243170rs3132486GArs3132486pha0028556.66E-13phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631243389rs3132485CArs3132485pha0028552.62E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631252925rs12191877CTrs12191877191692541.00E-100NA2.64NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs12191877-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
631252925rs12191877CTrs12191877209531884.00E-32NA2.79[2.35-3.33]472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
631252925rs12191877CTrs12191877pha0028552.02E-51phs0000192.77NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631259579rs2524163CTrs2524163pha0028555.33E-20phs0000191.67NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
631261276rs2243868AGrs2243868pha0028552.80E-19phs0000191.63NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631263751rs2894207TCrs2894207212149221.11E-16Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANACNA
631263751rs2894207TCrs2894207pha0028553.77E-38phs0000192.23NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631264392rs9380237GArs9380237pha0028552.58E-28phs0000191.89NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
631265057rs9468933TArs9468933pha0028551.62E-46phs0000192.63NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631265737rs2853923AGrs2853923pha0028552.70E-15phs0000191.56NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631266090rs4406273GArs4406273231435944.5E-723NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
631268832rs9380240TCrs9380240pha0028554.41E-14phs0000191.54NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631270118rs9468937CArs9468937pha0028554.83E-12phs0000191.45NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631273745rs3873386TCrs3873386pha0028551.17E-12phs0000191.54NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
631274555rs10484554CTrs10484554183694592.00E-39NA2.8[2.40-3.30]218 cases; 519 controlsNOPOP(737)ALL(737)NOPOP(737)ALL(737)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs10484554-TNANANA
631274555rs10484554CTrs10484554209531904.00E-214NA4.66[4.23-5.13]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tNA
631312326rs3134792TGrs3134792175870573.77E-09PsoriasisNANA318 European ancestry cases; 288 European ancestry controlsEuropean(606)ALL(606)EUR(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tComparative Study
631312326rs3134792TGrs3134792183643901.00E-09 NANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
631317347rs2156875CTrs2156875pha0028553.71E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631320538rs2442719CTrs2442719pha0028552.81E-13phs0000191.52NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631355119rs13437088CTrs13437088pha0028552.54E-13phs0000191.54NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
631361837rs10947208AGrs10947208pha0028552.18E-12phs0000191.53NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631384331rs9266844GCrs9266844pha0028551.02E-11phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631384889rs9266846CGrs9266846212149223.03E-07Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANANANA
631384889rs9266846CGrs9266846pha0028552.44E-11phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631388109rs9501106GArs9501106pha0028553.53E-16phs0000191.76NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631388595rs9295993AGrs9295993pha0028551.34E-15phs0000191.65NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631407643rs7772549TCrs7772549pha0028551.03E-11phs0000191.48NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANANANANANA
631431780rs2395029TGrs2395029183694592.00E-26NA4.1[3.10-5.30]218 cases; 519 controlsNOPOP(737)ALL(737)NOPOP(737)ALL(737)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs2395029-CNANAHCP5
631490480rs9267463GArs9267463pha0028551.10E-23phs0000192.59NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
631490646rs9267464CTrs9267464pha0028551.81E-22phs0000192.51NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
631494738rs2734573CArs2734573pha0028551.50E-12phs0000191.49NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATMCCD1nearGene-5NM_001011700
631544189rs3093662AGrs3093662pha0028554.75E-21phs0000192.31NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAATNFintronNM_000594
631553194rs9267502GArs9267502pha0028553.79E-19phs0000192.19NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAALST1nearGene-5NM_007161
631669295rs2295663AGrs2295663pha0028558.40E-24phs0000192.62NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATABHD16AintronNM_021160
631883679rs9267673CTrs9267673pha0028552.30E-33phs0000192.6NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACC2intronNM_001178063
632020844rs2077580GArs2077580pha0028557.45E-32phs0000192.61NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGTNXBintronNM_019105
632146997rs3132965AGrs3132965pha0028558.39E-16phs0000191.67NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACRNF5intronNM_006913
632148403rs8365GCrs8365pha0028551.09E-17phs0000191.1NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACRNF5UTR-3NM_006913
632158319rs176095AGrs176095pha0028552.18E-12phs0000191.1NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
632163274rs8192583GArs8192583pha0028552.25E-20phs0000192.58NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNOTCH4cds-synonNM_004557
632185796rs8192591CTrs8192591pha0028553.40E-24phs0000193.24NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNOTCH4missenseNM_004557
632190406rs443198AGrs443198pha0028551.53E-11phs0000191.46NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNOTCH4cds-synonNM_004557
632219041rs6916062CTrs6916062pha0028552.52E-22phs0000192.94NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACNANANA
632266506rs6906662GArs6906662pha0028552.11E-14phs0000192.09NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGC6orf10intronNM_006781
632399286rs9501624AGrs9501624pha0028552.36E-12phs0000191.87NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
632400190rs7762370TCrs7762370pha0028555.13E-19phs0000192.44NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
632429643rs9268853TCrs9268853pha0028558.87E-13phs0000191.5NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
632666721rs2856726ATrs2856726pha0028555.09E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
632679591rs12203586GCrs12203586pha0028555.74E-12phs0000191.47NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGNANANA
632681049rs2647087ACrs2647087212149221.21E-08Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAANA
632681049rs2647087ACrs2647087pha0028551.87E-16phs0000191.62NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAANANANA
632681085rs2858333AGrs2858333212149221.23E-08Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANATNA
632681085rs2858333AGrs2858333pha0028558.55E-16phs0000191.6NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANATNANANA
632782112rs11575907CTrs11575907pha0028555.96E-19phs0000192.9NANAALL(0)ALL(0)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANAGHLA-DOBmissenseNM_002120
636341693rs9470263AGrs9470263183643907.34E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
637562703rs6458004TCrs6458004183643908.78E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
691150188rs1782449TCrs1782449209531902.40E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6103889182rs11156278CArs11156278209531908.79E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6103895135rs2207016CTrs2207016209531905.47E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6111655530rs465969GArs465969209531902.00E-16NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
6111673714rs240993TCrs240993209531905.00E-20NA1.25[1.16-1.34]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs240993-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT,C
6111696091rs458017TCrs458017209531902.00E-16NA1.37[1.22-1.54]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs458017-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
6111913262rs33980500CTrs33980500209531881.00E-16NANANA472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs33980500-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6111913262rs33980500CTrs33980500231435944.20E-45NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
6111922720rs13210247AGrs13210247209531887.31E-09NANANA472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6138197824rs582757CTrs582757231435942.20E-25NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
6138199417rs610604GTrs610604191692549.00E-12NA1.19NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs610604-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6138199417rs610604GTrs610604209531876.00E-12PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
6138199417rs610604GTrs610604209531907.00E-07NA1.22[1.13-1.32] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
6146855097rs11155474ACrs11155474209531907.30E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
6159506600rs2451258CTrs2451258231435940.000000034NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
725088336rs2526401ACrs2526401209531901.06E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
737374510rs6974491GArs6974491209531903.48E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
737382520rs17259252GArs17259252209531904.76E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
737386237rs2700987CArs2700987231435944.30E-09NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
752261483rs7802354TGrs7802354183643905.67E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
764904905rs17146452CArs17146452209531871.26E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
765552497rs313829AGrs313829209531875.44E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
778769110rs2302442CArs2302442183643907.12E-06NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
798767927rs13244262AGrs13244262209531892.70E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
7111246951rs2613611ACrs2613611183643905.19E-06NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
7134296733rs13228697TGrs13228697209531873.44E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
7134305426rs4142278CTrs4142278209531872.44E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
7138095694rs4728435TGrs4728435209531877.69E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
82975578rs7841865TCrs7841865209531904.98E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
83679446rs7007032CTrs7007032209531873.78E-08PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
83679446rs7007032CTrs7007032209531875.10E-08Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
83684199rs10088247CTrs10088247209531874.54E-09PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
83684199rs10088247CTrs10088247209531878.60E-09Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
83695148rs10216665AGrs10216665191692553.20E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
86104318rs10092383CGrs10092383209531902.40E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
86104318rs145225541CAACrs10092383209531902.40E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
818015120rs4557740TCrs4557740209531902.59E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
823610799rs1561105TGrs1561105191692552.20E-06NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesA
824729914rs7844382TCrs7844382183643902.43E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
842344238rs4368963GTrs4368963209531909.85E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
857565864rs12679072CTrs12679072209531877.03E-06PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
892909899rs3936419GArs3936419209531902.14E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG,A
899191257rs2447494GArs2447494209531876.37E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
8100133706rs7460625TGrs7460625183643903.97E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
8124776245rs12550235CTrs12550235209531907.10E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
8124776537rs13275308CArs13275308209531908.01E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
8124787892rs13253599GTrs13253599209531903.02E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
8124804669rs7828192CTrs7828192209531904.79E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
8124812933rs6470186TCrs6470186209531907.24E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
8137523980rs2255522GArs2255522183643907.22E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
913812685rs7866165GTrs7866165209531903.64E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
913825565rs11788150CArs11788150209531904.73E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
913849122rs1813529CTrs1813529209531903.54E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
913854176rs7021837TCrs7021837209531901.02E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
927409264rs2225389TGrs2225389183643906.47E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
932431306rs12555576GArs12555576209531901.35E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
932456656rs12555727GArs12555727209531901.91E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
932523737rs11795343TCrs11795343231435948.40E-11NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
935635683rs1890592TGrs1890592209531892.50E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
986886897rs11790651GTrs11790651209531873.46E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
987281307rs1307279CTrs1307279209531876.34E-06PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
987387622rs1573219AGrs1573219209531871.71E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
9110817020rs10979182AGrs10979182231435940.000000023NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
9135298917rs1412272CTrs1412272183643909.78E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
9135776034rs1076160CTrs1076160191692546.00E-06NA1.09NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs1076160-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
9135776034rs1076160CTrs1076160209531876.00E-06PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
106631223rs10737105CGrs10737105209531893.90E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1050381921rs10857437GArs10857437183643901.73E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1064159333rs3758490GTrs3758490183643906.28E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1072859876rs11497787AGrs11497787209531909.58E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1081032532rs1250546AGrs1250546231435940.00000068NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1088945341rs7080675TCrs7080675209531906.36E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC,T
1089462990rs3781191AGrs3781191209531906.27E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
10130272033rs7096455GTrs7096455183643902.94E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1115182729rs1109328TCrs1109328183643902.63E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1126009705rs11029058GArs11029058209531903.71E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT,A
1144919413rs11038190TCrs11038190209531901.72E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1149760350rs11040503CArs11040503209531902.92E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1160547604rs2089343CArs2089343209531891.40E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1164135298rs645078ACrs645078231435940.0000022NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1196041692rs559477CArs559477209531902.21E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
11109956346rs7115956CTrs7115956209531905.54E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
11109962432rs4561177AGrs4561177231435947.70E-13NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
11109995287rs1789369CTrs1789369209531909.40E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
11120099368rs692804TCrs692804191692552.70E-06NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesA
11128189101rs4937314AGrs4937314209531894.20E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
11128406438rs3802826AGrs3802826231435949.50E-10NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
126039623rs11613774GArs11613774209531903.44E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1224392816rs884440GArs884440183643901.77E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1256439209rs12580100AGrs12580100209531891.00E-06NA1.17NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs12580100-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1256737973rs2066808AGrs2066808191692541.00E-09NA1.34NA1,359 cases; 1,400 controlsNOPOP(2759)ALL(2759)NOPOP(2759)ALL(2759)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs2066808-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1256737973rs2066808AGrs2066808209531871.00E-09PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1256737973rs2066808AGrs2066808209531902.00E-07NA1.49[1.28-1.73] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1256750204rs2066819CTrs2066819231435945.40E-17NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
12125429725rs10082832GArs10082832191692552.70E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
12126900016rs1014153GTrs1014153183643904.97E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
12127404403rs10773338GArs10773338191692553.00E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
12133498344rs13273GArs13273183643907.34E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1320762956rs3751385AGrs3751385209531872.20E-11Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1320762956rs3751385AGrs3751385209531874.40E-08PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1320896618rs7337231TCrs7337231191692554.60E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1320910048rs12868032TCrs12868032191692557.80E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1330496598rs17503263CTrs17503263209531901.44E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1340350912rs7993214TCrs7993214183694592.00E-06NA1.41[1.22-1.61] 218 cases; 519 controlsNOPOP(737)ALL(737)NOPOP(737)ALL(737)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNANACCOG6
1350424677rs11616903TCrs11616903209531909.87E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1350441861rs9535388GArs9535388209531903.95E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1350443678rs9526615TCrs9526615209531902.01E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1350446164rs9562933AGrs9562933209531901.66E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1350724055rs809845CTrs809845209531901.45E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1356886412rs9527499AGrs9527499209531876.57E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1356893428rs7998333AGrs7998333209531876.57E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1378008154rs9600888AGrs9600888209531902.46E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1378019766rs10467634TCrs10467634209531903.07E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1378021218rs7317940GA,Crs7317940209531907.83E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1397941497rs7999382TGrs7999382209531873.64E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
13107566858rs840225CTrs840225209531872.98E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
13110330521rs9521469GArs9521469209531874.73E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
13111147846rs912946GArs912946209531905.29E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
13114241227rs11617870GA,Trs11617870183643903.45E-06NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1423985973rs222671AGrs222671209531908.00E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1423986009rs17794441GTrs17794441209531904.77E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1423988786rs12894083GArs12894083209531903.58E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1425290697rs3759644TCrs3759644209531902.94E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1435682172rs12586317TCrs12586317209531892.00E-08NA1.15NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs12586317-TResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1435832666rs8016947TGrs8016947209531902.00E-11NA1.19[1.11-1.27]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs8016947-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1435832666rs8016947TGrs8016947231435942.50E-17NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1435839236rs2145623GCrs2145623209531885.01E-06NANANA472 German cases; 1,146 German controlsGerman(1618)ALL(1618)EUR(1618)ALL(1618)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1435871093rs696CTrs696209531891.80E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1450585248rs2227276CA,G,Trs2227276209531879.97E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1473246426rs11622025CArs11622025209531909.60E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1473247540rs758915AGrs758915209531908.84E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1473260377rs12435382GArs12435382209531908.31E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1473260475rs12435412GArs12435412209531907.92E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1476370358rs8015239ACrs8015239183643909.38E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1493687258rs17128943GArs17128943209531875.64E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
14101360168rs7160787CTrs7160787183643901.76E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1525864062rs9806169GTrs9806169183643903.86E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1532992487rs12708490GTrs12708490209531878.95E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1551981291rs2305716CTrs2305716183643904.74E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1552349355rs4627278GArs4627278183643903.68E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1570721586rs8038308GArs8038308209531874.92E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1570721927rs4777268CTrs4777268209531872.12E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1581427307rs2048271GArs2048271209531893.00E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1586075462rs6496066ACrs6496066209531908.16E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1610886823rs11866645TCrs11866645209531871.96E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1611365500rs367569CTrs367569231435940.000000049NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1613421017rs12926625CTrs12926625209531907.39E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1620418452rs6416610TCrs6416610183643908.22E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1626141819rs4544246GArs4544246209531907.25E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1627147284rs1913895CTrs1913895209531904.14E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1630877544rs4889630TCrs4889630191692553.90E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1630903679rs9933843CTrs9933843191692557.70E-06NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1630942625rs10782001GArs10782001209531899.00E-10NA1.16NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs10782001-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1630970741rs2305884GArs2305884191692551.40E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1630980902rs897986TCrs897986191692551.40E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
1631004812rs12445568TCrs12445568231435941.20E-16NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1653816275rs8050136CArs8050136209531891.50E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1674301477rs9673539GArs9673539209531872.85E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1674758984rs2240245AGrs2240245209531908.43E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1682786040rs4395067GArs4395067209531909.57E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1682812959rs12920400CArs12920400191692554.70E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
1717444369rs4646388GArs4646388209531909.88E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1721707060rs1975974AGrs1975974209531891.00E-07NA1.17NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs1975974-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1721717543rs17052344GArs17052344209531893.80E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1726106675rs4795067AGrs4795067209531894.00E-11NA1.19NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs4795067-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1726124908rs28998802GArs28998802231435943.30E-16NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1728296327rs9897794TGrs9897794209531901.66E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1728410124rs12941382TCrs12941382209531902.19E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1728410324rs12948898GArs12948898209531901.93E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1740561579rs963986GCrs963986231435945.30E-09NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1766812495rs4254382TCrs4254382209531874.62E-06PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1768395219rs1860454GArs1860454191692551.30E-05NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesG
1769768587rs713122ACrs713122183643904.58E-06NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1770274865rs11077598GArs11077598209531901.42E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1770289225rs4793422CTrs4793422209531902.39E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1770299817rs4793426ACrs4793426209531904.01E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1770299958rs17181550TGrs17181550209531909.33E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1773519413rs8064529CTrs8064529209531905.28E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1778178893rs11652075CTrs11652075231435940.000000034NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1851819750rs545979CTrs545979231435943.50E-10NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1853210302rs613872GTrs613872183643908.93E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1855517372rs4346276TGrs4346276209531874.38E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1860941958rs7242402CTrs7242402209531877.88E-04PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1861656785rs514315TCrs514315209531871.20E-09Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1861656785rs514315TCrs514315209531872.99E-09PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1864250279rs12955031TGrs12955031183643906.72E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1866754553rs17080308CTrs17080308209531904.78E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1870843010rs1158869CTrs1158869191692559.80E-06NANANA1,139 Chinese ancestry cases; 1,132 Chinese ancestry controlsChinese(2271)ALL(2271)ASN(2271)ALL(2271)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, Non-U.S. Gov'tValidation StudiesC
192238667rs7253181GTrs7253181209531901.87E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1910463118rs34536443GCrs34536443231435949.10E-31NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1910469975rs12720356ACrs12720356209531904.00E-11NA1.4[1.23-1.61]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs12720356-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1910472933rs280519AGrs280519209531904.00E-09NA1.13[1.05-1.21] 2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs280519-AResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1910798904rs2569507GArs2569507209531891.80E-05NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1910818092rs892085GArs892085231435943.00E-17NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
1929749444rs4805358TCrs4805358209531906.51E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
1934131461rs8105751AGrs8105751209531902.56E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1939763765rs7359950CTrs7359950209531905.90E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
1946547330rs1114090AGrs1114090183643909.62E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
1949207206rs485186AGrs485186209531909.74E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1949211969rs676388TCrs676388209531909.82E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
1953451291rs9304742TCrs9304742209531871.80E-10Psoriasis (Type 1)NANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
1953451291rs9304742TCrs9304742209531872.11E-09PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
202372985rs6083041GArs6083041209531903.11E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
206015940rs6117041TCrs6117041183643906.98E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2018375581rs4361192TCrs4361192183643904.70E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2043980726rs1008953TCrs1008953209531891.00E-07NA1.14NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs1008953-CResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2048522330rs495337GArs495337183643901.00E-08 1.25[1.12-1.39] 318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2048522330rs495337GArs495337209531892.00E-07NA1.21NAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisrs495337-GResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2048522330rs495337GArs495337209531902.00E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2048554977rs2235617CGrs2235617209531902.00E-06NA1.2[1.11-1.30]2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
2048556229rs1056198CTrs1056198231435941.50E-14NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2055682387rs717908AGrs717908209531893.00E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2060467272rs4925207CTrs4925207209531909.44E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2125241468rs2828571TGrs2828571183643909.31E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2136488822rs17812953TCrs17812953209531891.70E-04NANANAUp to 1,831 cases; 2,546 controlsNOPOP(4377)ALL(4377)NOPOP(4377)ALL(4377)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2147546244rs13050660TCrs13050660209531907.08E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tC
2219962203rs2239395TGrs2239395183643905.89E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2221912272rs390408AGrs390408209531908.80E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA
2221979289rs4821124TCrs4821124231435940.000000038NANANA10588 European ancestry cases; 22806 European ancestry controlsEuropean(33394)ALL(33394)EUR(33394)ALL(33394)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralMeta-AnalysisResearch Support, Non-U.S. Gov't
2222046787rs12170039GArs12170039209531903.43E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tA,G
2222055280rs710172AGrs710172209531903.35E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
2223895043rs179307AGrs179307183643907.07E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tNA
2227717716rs497150AGrs497150212149221.67E-05Prediction of psoriasis case statusNANA1384 cases; 1414 controls NOPOP(2798)ALL(2798)NOPOP(2798)ALL(2798)Psoriasis risk predictionHPOID:0003765PsoriasisDOID:8893psoriasisNANANANAPsoriasisNANAA,GNA
2249204613rs8139003AGrs8139003209531873.24E-05PsoriasisNANA1139 Chinese cases; 1227 Chinese controlsChinese(2366)ALL(2366)ASN(2366)ALL(2366)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.
X38585148rs35233462GArs35233462209531903.92E-06NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
X53329263rs2480443TCrs2480443183643905.12E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
X62600135rs12006616AGrs12006616209531909.08E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tG
X117421376rs1781951TCrs1781951209531907.48E-05NANANA2,178 European ancestry cases; 5,175 European ancestry controlsEuropean(7353)ALL(7353)EUR(7353)ALL(7353)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
X127083976rs5974980TCrs5974980183643902.74E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
X127223056rs683335CArs683335183643903.49E-05NANANA318 cases; 288 controlsNOPOP(606)ALL(606)NOPOP(606)ALL(606)PsoriasisHPOID:0003765PsoriasisDOID:8893psoriasisD011565PsoriasisEFOID:0000676psoriasisPsoriasisNAResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tT
Mapped by lexical matching(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0002671Basal cell carcinomaMP:0004207increased squamous cell carcinoma incidence;HP:0002206Pulmonary fibrosis
Mapped by homologous gene(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0002671Basal cell carcinomaMP:0009873abnormal aorta tunica media morphology;HP:0002149Hyperuricemia
Chemical(Total Drugs:20)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0033860acitretinD01725555079-83-9psoriasisMESH:D011565therapeutic11922592
C0033860adapaleneD000068816-psoriasisMESH:D011565therapeutic21864882
C0033860amcinonideC012716-psoriasisMESH:D011565therapeutic3891239
C0033860azelaic acidC010038-psoriasisMESH:D011565therapeutic20684146
C0033860betamethasoneD001623378-44-9psoriasisMESH:D011565therapeutic851765
C0033860colchicineD00307864-86-8psoriasisMESH:D011565therapeutic9848464
C0033860cyclosporineD01657259865-13-3psoriasisMESH:D011565therapeutic16882103
C0033860dapsoneD00362280-08-0psoriasisMESH:D011565therapeutic19583683
C0033860calcitriolD00211732222-06-3psoriasisMESH:D011565therapeutic10086871
C0033860folic acidD00549259-30-3psoriasisMESH:D011565therapeutic15807694
C0033860hydroxyureaD006918127-07-1psoriasisMESH:D011565therapeutic10354169
C0033860mefloquineD01576753230-10-7psoriasisMESH:D011565marker/mechanism9882160
C0033860methotrexateD0087271959/5/2psoriasisMESH:D011565therapeutic10413333
C0033860methoxsalenD008730298-81-7psoriasisMESH:D011565therapeutic12925193
C0033860pimecrolimusC117268-psoriasisMESH:D011565therapeutic16033622
C0033860sirolimusD02012353123-88-9psoriasisMESH:D011565therapeutic10328196
C0033860tacrolimusD016559109581-93-3psoriasisMESH:D011565therapeutic15948985
C0033860tretinoinD014212302-79-4psoriasisMESH:D011565therapeutic21274875
C0033860troglitazoneC05769397322-87-7psoriasisMESH:D011565therapeutic10815854
C0033860vitamin aD01480111103-57-4psoriasisMESH:D011565therapeutic14746632
FDA approved drug and dosage information(Total Drugs:4)
DiseaseID Drug_name active_ingredients strength Dosage Form/Route Marketing Status TE code RLD RS
MESH:D011565calcijexcalcitriol0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasonsINJECTABLE;INJECTIONDiscontinuedNoneYesNo
MESH:D011565elidelpimecrolimus1%CREAM;TOPICALPrescriptionNoneYesYes
MESH:D011565rapamunesirolimus1MG/MLSOLUTION;ORALPrescriptionNoneYesYes
MESH:D011565rapamunesirolimus1MGTABLET;ORALPrescriptionABYesNo
FDA labeling changes(Total Drugs:4)
DiseaseID Pediatric_Labeling_Date Trade_Name Generic_Name_or_Proper_Name Indications Studied Label Changes Summary Product Labeling BPCA(B) PREA(P) BPCA(B) and PREA(P) Pediatric Rule (R) Sponsor Pediatric Exclusivity Granted Date NNPS
MESH:D01156511/16/2001calcijexcalcitriolManagement of hypocalcemia in patients undergoing chronic renal dialysisThe safety and effectiveness of calcitriol was examined in a double-blind placebo-controlled trial of 35 pediatric patients (13-18 years of age) with end-stage renal disease and on dialysis. The primary efficacy endpoint favored the calcitriol-treated versus the placebo-treated patients Transient hypercalcemia was seen in 1 of 16 calcitriol-treated patients; 6 of 16 (38%) calcitriol-treated patients and 2 of 19 (11%) placebo-treated patients had Ca x P >75LabelingB---Abbott02/16/2001FALSE'
MESH:D01156512/13/2001elidelpimecrolimusTreatment of mild/moderate atopic dermatitisIndicated for short-term and intermittent long-term therapy for mild to moderate atopic dermatitis in non-immunocompromised patients 2 years and older Not recommended for use in pediatric patients less than 2 years of age. Infants on Elidel Cream had an increased incidence of some adverse events compared to vehicle which included pyrexia, URI, nasopharyngitis, gastroenteritis, otitis media, and diarrhea.LabelingB---Novartis09/24/2001FALSE'
MESH:D01156511/3/2005rapamunesirolimusProphylaxis of organ rejection in patients undergoing renal transplantsSafety and efficacy established in children 13 years or older judged to be at low to moderate immunologic risk Safety was assessed in a controlled clinical trial in pediatric (LabelingB---Wyeth11/17/2004FALSE'
MESH:D01156511/3/2005rapamunesirolimusProphylaxis of organ rejection in patients undergoing renal transplantsSafety and efficacy established in children 13 years or older judged to be at low to moderate immunologic risk Safety was assessed in a controlled clinical trial in pediatric (LabelingB---Wyeth11/17/2004FALSE'